{"text": "In this study , we identified HER2 amplification in diagnostic specimens of PDAC using single nucleotide polymorphism ( SNP ) arrays and whole genome sequencing .", "label": "", "metadata": {}, "score": "44.542442"}
{"text": "Finally , there is potential for anti - HER2 therapies in this subset of patients .In situ hybridization studies in our reference laboratory identified HER2 amplification only in PDACs with high protein expression by IHC ( score 2+/3 + ) .", "label": "", "metadata": {}, "score": "52.869072"}
{"text": "The same analysis was performed for the subgroup of patients with intestinal type .In this case , no prognostic value for HER2 protein overexpression or for its amplification determined by FISH was observed .", "label": "", "metadata": {}, "score": "53.570015"}
{"text": "To our knowledge , these are the only available data concerning hERG1 in GC addressing hERG1 as a negative prognostic factor .On the contrary when performing a study in a larger cohort of 524 GC patients ( manuscript in preparation ) encompassing different stages of the disease , we obtained different conclusions .", "label": "", "metadata": {}, "score": "53.678955"}
{"text": "One of the possible explanations for this discrepancy might be different specimen types and reagents .The majority of current studies using a standard guideline for HER2 expression assessment used biopsies and tissue microarrays ( TMAs ) , which were tested analogous to biopsies , to interrogate HER status in GC .", "label": "", "metadata": {}, "score": "54.352257"}
{"text": "Since the completion of this study , we have begun prospectively screening patients with PDAC for HER2 amplification using this diagnostic approach , and identified a further two individuals ( of eleven ) with HER2 amplification .", "label": "", "metadata": {}, "score": "54.46189"}
{"text": "12 Our group has demonstrated the concordance between the FISH and dc - SISH techniques for determining HER2 gene amplification in GC samples .Materials and methods .", "label": "", "metadata": {}, "score": "54.580517"}
{"text": "Evaluation time .During the study , the evaluation time for each specimen was recorded for HER2 CISH and PathVysion FISH assays allowing for a comparison of evaluation times .", "label": "", "metadata": {}, "score": "54.923218"}
{"text": "We have developed a protocol that allows simultaneous visualization of the HER2 IHC and HER2 & CEN17 BISH targets .This automated protocol facilitated the determination of HER2 protein and HER2 gene status in randomly selected breast cancer samples , particularly in cases that were equivocal or exhibited tumor heterogeneity .", "label": "", "metadata": {}, "score": "55.345924"}
{"text": "Conclusion We have successfully developed an automated BDISH application for HER2 gene and CEN 17 targets in forma- lin - fixed , paraffin - embedded tissue sections that is highly concordant to the FISH and is reproducibly interpreted among observers .", "label": "", "metadata": {}, "score": "55.495872"}
{"text": "Results .In the initial set of 50 patients recruited to the APGI , SNP arrays detected a case of HER2 amplification ( Figure 1 A ) , with associated high HER2 mRNA expression ( see Additional file 4 ) .", "label": "", "metadata": {}, "score": "56.649254"}
{"text": "In addition , varying methods of evaluation and scoring schemes with different cut - points were used before the establishment of a standard guideline for assessing HER2 expression .", "label": "", "metadata": {}, "score": "56.739845"}
{"text": "There were no statistically significant differences in HER2 overexpression by IHC results according to sex , age or metastatic site .Likewise , no statistically significant differences were observed in HER2 amplification results obtained by FISH or dc - SISH according to age and sex .", "label": "", "metadata": {}, "score": "56.949238"}
{"text": "Those which are easily detectable and quantifiable through IHC will be the object of the present review .In particular , we will focus on HER2 , a well - known GC marker , whose determination is mandatory in GC , a marker whose correlation with prognosis is still controversial , VEGFs and quite novel , unconventional marker , hERG1 .", "label": "", "metadata": {}, "score": "57.29972"}
{"text": "HER2 and CEN 17 copy numbers produced with the sin- gle target ISH and BDISH methods matched with previ- ously reported results .As both probes are labeled with the same DNP hapten , our first concern was to determine if detecting specific signal for each probe was feasible .", "label": "", "metadata": {}, "score": "57.490498"}
{"text": "Another possibility , which was revealed by a study aiming to validate the guideline for HER2-expression assessment in GC , was different interpretations of staining of TMAs among observers , although a uniform assessment guideline was followed [ 22 ] .", "label": "", "metadata": {}, "score": "57.943085"}
{"text": "Results of the clinicopathological correlation with HER2 status in our series are similar to those described in previous studies , with a high correlation with the presence of the intestinal histological type , particularly when HER2 amplification techniques were used .", "label": "", "metadata": {}, "score": "58.30223"}
{"text": "A more recent paper by the same group [ 97 ] demonstrated the correlation between hERG1 expression and tumor grading and TNM stage .Furthermore , inhibition of the channel with specific siRNAs resulted in a reduction of tumor growth and colony formation .", "label": "", "metadata": {}, "score": "58.38166"}
{"text": "Also , there was a tendency towards differences between HER2 /CEN-17 ratios in highly amplified specimens between HER2 CISH and FISH assays ( see Figure 2 and 3 ) .", "label": "", "metadata": {}, "score": "58.45794"}
{"text": "G12D [ 9 ] .Given the small numbers of HER2 -amplified cases , further studies of larger cohorts will be required before it can be determined if this association is sufficiently robust to be used diagnostically or targeted therapeutically .", "label": "", "metadata": {}, "score": "58.660065"}
{"text": "Statistical analysis was performed using the chi - square test to analyze associations between HER2 status and clinicopathological parameters .A P value less than 0.05 was considered significant .", "label": "", "metadata": {}, "score": "59.017567"}
{"text": "To determine the frequency of HER2 gene amplification or overexpression in the tumour tissue samples the following assay methods were used : IHC , FISH and dc - SISH .", "label": "", "metadata": {}, "score": "59.615547"}
{"text": "Results The amplification status based solely on HER2 signals was 98 % concordant with results of dual - probe FISH .In non - amplified tumours , the mean CEP17 and HER2 copy number correlated , possibly because of cell cycling .", "label": "", "metadata": {}, "score": "59.74482"}
{"text": "Discordant cases .Samples amplified by FISH and dc - SISH , considered as a positive control for HER2 gene amplification , were all found to be amplified using the RT - PCR quantitative approach .", "label": "", "metadata": {}, "score": "59.7731"}
{"text": "The HER2 protein and HER2 gene status obtained using the multiplex HER2 gene - protein assay demonstrated high concordance with those obtained using the separate HER2 IHC and HER2 & CEN17", "label": "", "metadata": {}, "score": "59.91951"}
{"text": "The findings may be helpful in optimising the methodology of HER2 testing .Therefore , the aim of this study was to perform FISH testing for HER2 in a large number of breast tumours , irrespective of the IHC scores , which were also determined in all cases .", "label": "", "metadata": {}, "score": "59.95647"}
{"text": "Not only the ratio , but also mean HER2 and CEP17 copy number were determined and used in statistical analyses to evaluate relationships between FISH , IHC and clinicopathological features .", "label": "", "metadata": {}, "score": "60.13916"}
{"text": "Clinically , HER2 - amplified PDAC was characterized by a lack of liver metastases , and a preponderance of lung and brain metastases .Conclusions .", "label": "", "metadata": {}, "score": "60.29744"}
{"text": "View Article .Arena V , Pennacchia I , Vecchio FM , Carbone A : \" CISH the FISH \" for HER2 : our laboratory experience .", "label": "", "metadata": {}, "score": "60.329338"}
{"text": "BISH assays .HER2 protein detection was optimal when the HER2 IHC protocol was used before ( rather than after ) the BISH protocol .The sequential use of HER2 IHC and HER2 & CEN17", "label": "", "metadata": {}, "score": "60.42865"}
{"text": "G12V and SMAD4 , further supporting the diagnosis of PDAC .HER2 amplification in other cancer types .The low prevalence of HER2 amplification in PDAC and many other cancer types makes clinical trials challenging .", "label": "", "metadata": {}, "score": "60.62434"}
{"text": "The comparison also revealed that significantly higher HER2 /CEN-17 ratios and higher CEN-17 signal copy numbers were observed for HER2 CISH compared to HER2 FISH and PathVysion FISH , whereas no significant difference were observed between HER2 signals ( Table 5 ) .", "label": "", "metadata": {}, "score": "60.83741"}
{"text": "After single staining for HER2 gene or CEN 17 was optimized , the BDISH applica- tion with sequential detection for HER2 targets followed by CEN 17 targets was tested on xenograft tumors .", "label": "", "metadata": {}, "score": "60.955444"}
{"text": "Discussion .Previously published studies have reported high concordance between HER2 FISH and HER2 CISH performed in breast cancer specimens [ 7 , 15 - 19 ] , however , larger studies that validate the use of HER2 CISH have not yet been presented .", "label": "", "metadata": {}, "score": "61.003532"}
{"text": "A specific study evaluating HER2 protein expression on whole - tissue sections and TMAs was conducted , indicating a discrepancy in HER2 expression on whole - tissue sections from TMAs .", "label": "", "metadata": {}, "score": "61.0271"}
{"text": "The same conclusion was reached in a US and European collaborative analysis recently presented by Shah et al at the ASCO 2011 meeting . 10However , in the subgroup analysis based on tumour histology and HER2 status , only HER2 amplification determined by means of dc - SISH was deemed to be of prognostic value for intestinal type patients .", "label": "", "metadata": {}, "score": "61.147736"}
{"text": "L. J. Tafe , Y. Y. Janjigian , M. Zaidinski et al . , \" Human epidermal growth factor receptor 2 testing in gastroesophageal cancer : correlation between immunohistochemistry and fluorescence in situ hybridization , \" Archives of Pathology and Laboratory Medicine , vol .", "label": "", "metadata": {}, "score": "61.15558"}
{"text": "A few papers addressing the expression and role of hERG1 in GC have been published so far . hERG1 channels are expressed in GC cell lines , where their activity regulates cell proliferation in vitro [ 95 , 96 ] .", "label": "", "metadata": {}, "score": "61.210503"}
{"text": "Defining HER 2 amplification as a biomarker of trastuzumab responsiveness is integral to targeting appropriate populations for therapy .Although HER2 overexpression and amplification has been assessed in PDAC ( see Additional file 1 ) , standardized diagnostic assays have on the whole not been applied , and the roles of emerging diagnostic approaches such as genomic sequencing are yet to be explored .", "label": "", "metadata": {}, "score": "61.36291"}
{"text": "The slides were counterstained with hematoxylin and mounted in a permanent mounting medium .HER2 CISH stained slides were interpreted using a bright field microscope with 40\u00d7 and 60\u00d7 objectives .", "label": "", "metadata": {}, "score": "61.421196"}
{"text": "Here we report its analytical properties when applied by an automated immunohistochemistry method .Methods and resultsExcellent antibody specificity was demonstrated by immunoblot , ELISA , and IHC evaluation of characterised cell lines including NIH3T3 overexpressing the related kinase MST1R ( RON ) .", "label": "", "metadata": {}, "score": "61.560364"}
{"text": "In this study , the frequency of HER2 expression and the relationship between HER2 expression and clinicopathological features were examined in a large cohort of Chinese GC and GEJ cancer patients .", "label": "", "metadata": {}, "score": "61.77543"}
{"text": "Interpretation of HER2 and CEN 17 BDISH slides was conducted by 4 observers using a conventional brightfield microscope without oil immersion objectives .Sequential hybridization and signal detection for HER2 and CEN 17 ISH demonstrated both DNA targets in the same cells .", "label": "", "metadata": {}, "score": "61.78893"}
{"text": "In recent years , several molecules have been identified and tested for their clinical relevance in GC management .In this paper , we will focus on a well - known GC marker , whose determination is mandatory in GC , HER2 , a marker whose correlation with prognosis is still controversial ( VEGF - A ) and a quite novel , unconventional marker , the ether - \u00e0 - go - go - related gene 1 ( hERG1 ) .", "label": "", "metadata": {}, "score": "61.887123"}
{"text": "In GC , HER2 acts as an oncogene , since gene amplification reflects in protein overexpression , therefore giving selective advantage to malignant cells .In GC , HER2 overexpression has been correlated with poor outcome and a more aggressive disease [ 20 ] as well as with shorter survival [ 19 - 22 , 61 - 65 ] .", "label": "", "metadata": {}, "score": "62.030792"}
{"text": "Results .The data obtained revealed an overall HER2 status concordance of approximately 98 % for comparisons of HER2 CISH pharmDx \u2122 Kit to both HER2 FISH pharmDx \u2122 Kit and PathVysion HER-2 DNA Probe Kit .", "label": "", "metadata": {}, "score": "62.100624"}
{"text": "A 101 bp fragment of the HER2 gene and a 119 bp fragment of the RPL23 reference gene , both localised on chromosome 17q21 , were amplified according to the manufacturer 's instructions .", "label": "", "metadata": {}, "score": "62.24388"}
{"text": "We found that HER2 -amplified PDAC has an atypical pattern of metastatic spread with a predilection for lung metastasis and local recurrence , rather than liver metastases .", "label": "", "metadata": {}, "score": "62.32338"}
{"text": "No relation was found between MVD and VEGF - C expression , but VEGF - C and MVD turned out to be related to clinicopathological features [ 79 ] .", "label": "", "metadata": {}, "score": "62.435814"}
{"text": "PubMed View Article .Bhargava R , Lal P , Chen B : Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low - level amplification : does it measure up to fluorescence in situ hybridization ?", "label": "", "metadata": {}, "score": "62.722057"}
{"text": "In a large multicentric trial carried out on GC patients ( ToGA study ) , a survival benefit of trastuzumab ( herceptin ) treatment in HER2-positive patients ( IHC score 3 + ) has been shown [ 23 ] .", "label": "", "metadata": {}, "score": "62.732147"}
{"text": "Authors ' Affiliations .Dako Denmark A / S .References .Ross JS , Slodkowska EA , Symmans WF , Pusztai L , Ravdin PM , Hortobagyi GN : The HER-2 receptor and breast cancer : ten years of targeted anti - HER-2 therapy and personalized medicine .", "label": "", "metadata": {}, "score": "62.949455"}
{"text": "PubMed View Article .Kim KC , Koh YW , Chang HM , Kim TH , Yook JH , Kim BS , Jang SJ , Park YS : Evaluation of HER2 protein expression in gastric carcinomas : comparative analysis of 1,414 cases of whole - tissue sections and 595 cases of tissue microarrays .", "label": "", "metadata": {}, "score": "62.991997"}
{"text": "16 .Fluorescence in situ hybridisation .HER2 copy number was investigated by FISH using the PathVysion HER2 DNA probe kit ( Vysis Inc , Abbot Laboratories , Illinois , USA ) with the DAKO Histology FISH Accessory kit .", "label": "", "metadata": {}, "score": "63.039486"}
{"text": "Statistical analysis .The primary objective was to determine the frequency of HER2 gene amplification or overexpression in patients with advanced GC .Comparisons of the frequency of HER2 overexpression or amplification for different groups were performed using the Wilcoxon - Mann - Whitney test ( for two groups ) or the Kruskal - Wallis test ( for more than two groups ) .", "label": "", "metadata": {}, "score": "63.41594"}
{"text": "As a parallel study , the slide evaluation time was compared between HER2 CISH and PathVysion FISH and as could be expected the average evaluation time for a CISH staining was significantly shorter .", "label": "", "metadata": {}, "score": "63.721497"}
{"text": "Aim To study the HER2 gene amplification or overexpression in patients with advanced gastric cancer ( GC ) and their association with patient characteristics and patient survival .", "label": "", "metadata": {}, "score": "63.963463"}
{"text": "Simon R , Nocito A , Hubscher T , et al .: Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast Cancer .", "label": "", "metadata": {}, "score": "64.000824"}
{"text": "This likely overestimation underpowered the trials by over 80 % , making a negative result uninterpretable .Conclusion .HER2 amplification occurs in 2.1 % of PDAC cases , and is associated with an atypical pattern of metastatic disease .", "label": "", "metadata": {}, "score": "64.02559"}
{"text": "Using this approach , 8 % of PDAC ( 2 + and 3 + cancers ) will require HER2 ISH assessment , and of these one - quarter will be amplified .", "label": "", "metadata": {}, "score": "64.1132"}
{"text": "Standardization of HER2 testing procedures and interpretation is , therefore , an essential step to ensure accurate and reproducible results .As reported in Table 2 , samples are given a score according to the intensity , degree of membrane reactivity and the percentage of immunoreactive cells .", "label": "", "metadata": {}, "score": "64.128685"}
{"text": "Table 1 shows an overview of some of the biomarkers reported so far , along with the most correlated clinical parameters .With the exception of HER2 , none of the biomarkers reported in the table is currently used in clinical practice , and some of them were described in single studies .", "label": "", "metadata": {}, "score": "64.397804"}
{"text": "In both amplified and non - amplified tumours , a gene dosage effect was observed : an increase in the mean HER2 copy number was associated with a higher IHC score .", "label": "", "metadata": {}, "score": "64.45169"}
{"text": "This resulted in significantly lower HER2 /CEN-17 ratios observed for HER2 CISH .There was no clinical diagnostic impact of this change as the concordance agreement calculations revealed very fine agreement between HER2 CISH and the two FISH assays .", "label": "", "metadata": {}, "score": "64.45671"}
{"text": "a GC case with HER2 amplification using FISH analysis .Green signals refer to the reference probe of Chr .17 centromere , while red signals are the target probe for HER2 .", "label": "", "metadata": {}, "score": "64.46766"}
{"text": "Additionally , gene amplification was examined using fluorescent in situ hybridization ( FISH ) for HER2 .Positivity was defined as an IHC score of 3 + or an IHC score of 2+/FISH positive for HER2 , and an IHC score of 2 + or 3 + for both EGFR and c - MET .", "label": "", "metadata": {}, "score": "64.49583"}
{"text": "PubMed View Article .J Clin Oncol 2009 , 27 ( 15S ) : 4556 .Bozzetti C , Negri FV , Lagrasta CA , Crafa P , Bassano C , Tamagnini I , Gardini G , Nizzoli R , Leonardi F , Gasparro D : Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma .", "label": "", "metadata": {}, "score": "64.7799"}
{"text": "The study population was enriched for HercepTest \u2122 IHC 2 + specimens because most testing modalities pass on such equivocal specimens to a genetic test .", "label": "", "metadata": {}, "score": "64.78587"}
{"text": "5 , pp .649 - 655 , 1998 .View at Google Scholar \u00b7 View at Scopus . A. Masi , A. Becchetti , R. Restano - Cassulini et al . , \" hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines , \" British Journal of Cancer , vol .", "label": "", "metadata": {}, "score": "64.817825"}
{"text": "PubMed View Article .Ross JS , Fletcher JA : The HER-2/neu oncogene in breast cancer : prognostic factor , predictive factor , and target for therapy .", "label": "", "metadata": {}, "score": "64.82962"}
{"text": "PubMed View Article .Tanner M , Gancberg D , Di LA , Larsimont D , Rouas G , Piccart MJ , Isola J : Chromogenic in situ hybridization : a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples .", "label": "", "metadata": {}, "score": "64.917564"}
{"text": "Results .HER2 equivocal ( 2 + ) was detected in 14.4 % of cases .A high concordance rate ( 98.5 % ) between IHC and FISH was demonstrated .", "label": "", "metadata": {}, "score": "64.92855"}
{"text": "One prerequisite for testing HER2 status reproducibly is the use of automation for conducting the test in the same manner among different laboratories located in different parts of the world .", "label": "", "metadata": {}, "score": "64.95293"}
{"text": "For the three IHC 3 + discordant cases cluster amplification of blue ( CEN-17 ) signals was observed that covered red ( HER2 ) signals or made them difficult to see .", "label": "", "metadata": {}, "score": "65.00009"}
{"text": "Factors associated with favourable survival in the multivariate analysis were intestinal type and Her2 + determination by IHC , FISH or dc - SISH .Conclusion HER2 gene amplification is significantly associated with patient survival .", "label": "", "metadata": {}, "score": "65.10171"}
{"text": "Figure 5 : hERG1 potassium channel structure ; PAS : Per Arnt Sim domain , cNBD : cyclic nucleotide - binding domain . hERG1 constitutes the molecular basis of the cardiac rapid repolarizing current ( IKr ) ( reviewed in [ 83 ] ) and is therefore physiologically relevant to regulate the cardiac action potential [ 83 ] .", "label": "", "metadata": {}, "score": "65.150894"}
{"text": "To enable optimal management of this patient group , it is important to understand if the reported incidence of change in HER2 status of primary and metastatic breast cancer is real or an artefact of testing methodology .", "label": "", "metadata": {}, "score": "65.27516"}
{"text": "However , like the CISH assay , the detection of CEN 17 signal can not be performed on the same tissue section .Thus , it would be ideal to vis- ualize both HER2 and CEN 17 on the same tissue section like two - color FISH assays .", "label": "", "metadata": {}, "score": "65.368095"}
{"text": "HER2 gene signal was detected with a DNP - labeled nick translated DNA probe hybridization followed by silver signal detection system ( silver acetate , hydroquinone , and H2O2 reaction ) .", "label": "", "metadata": {}, "score": "65.38399"}
{"text": "( XLSX 97 KB ) .13073_2013_477_MOESM6_ESM . xlsx Additional file 6 : Table S7 : Genomic alterations within a patient identified with HER2 amplification .", "label": "", "metadata": {}, "score": "65.48351"}
{"text": "The HER2 & CEN17 BISH signals were visualized using horseradish peroxidase - based silver and alkaline phosphatase - based red detection systems , respectively with a cocktail of 2,4-dinitrophenyl - labeled HER2 and digoxigenin - labeled CEN17 probes .", "label": "", "metadata": {}, "score": "65.507324"}
{"text": "Exploratory analysis of copy numbers and ratio .Exploratory analysis of HER2 /CEN-17 ratios was performed by plotting ratios obtained by HER2 CISH as a function of ratios obtained by HER2 FISH ( Figure 2 ) or PathVysion FISH ( Figure 3 ) .", "label": "", "metadata": {}, "score": "65.5191"}
{"text": "However , there are additional drawbacks to conducting HER2 FISH assays beyond the requirement for a special- ized fluorescence microscope and the difficulty of preserv- ing FISH signal during a long term storage .", "label": "", "metadata": {}, "score": "65.528305"}
{"text": "PubMed View Article .Kallioniemi OP , Kallioniemi A , Kurisu W , Thor A , Chen LC , Smith HS , Waldman FM , Pinkel D , Gray JW : ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization .", "label": "", "metadata": {}, "score": "65.673996"}
{"text": "- assessing HER2 status in metastatic deposits of any case exhibiting heterogeneity in the primary tumour would appear to be warranted .Conclusion .In conclusion , the present study is one of the largest studies where paired primary and recurrence tissue samples were available for centralised ISH analysis .", "label": "", "metadata": {}, "score": "65.70201"}
{"text": "263 - 275 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. Ulyatt , J. Walker , and S. Ponnambalam , \" Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells , \" Biochemical and Biophysical Research Communications , vol .", "label": "", "metadata": {}, "score": "65.726166"}
{"text": "Am J Surg Pathol 2002 , 26:908 - 913 .Tubbs R , Pettay J , Hicks D , Skacel M , Powell R , Grogan T , Hainfeld J : Novel bright field molecular morphology methods for detec- tion of HER2 gene amplification .", "label": "", "metadata": {}, "score": "65.8284"}
{"text": "It has long been known that VEGF - A is the key regulator of tumor angiogenesis [ 75 ] , a complex process with a clear relevance to tumor progression and metastasis .", "label": "", "metadata": {}, "score": "65.88958"}
{"text": "Amplification of HER-2 in gastric carcinoma : association with Topoisomerase IIalpha gene amplification , intestinal type , poor prognosis and sensitivity to trastuzumab .Ann Oncol 2005 ; 16 : 273 - 8 . . .", "label": "", "metadata": {}, "score": "65.945595"}
{"text": "However , based on published images [ 28,42 ] , TMB stain- ing does not provide discrete signals when compared to the SISH application .HER2 and CEN 17 probes are co - hybridized for dual color HER2 FISH .", "label": "", "metadata": {}, "score": "65.9485"}
{"text": "View Article .Gancberg D , Di Leo A , Cardoso F , Rouas G , Pedrocchi M , Paesmans M , Verhest A , Bernard - Marty C , Piccart MJ , Larsimont D : Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites .", "label": "", "metadata": {}, "score": "65.954605"}
{"text": "163 - 167 , 2008 .View at Publisher \u00b7 View at Google Scholar . Y. Kato , M. Yashiro , S. Noda et al . , \" Expression of a hypoxia - associated protein , carbonic anhydrase-9 , correlates with malignant phenotypes of gastric carcinoma , \" Digestion , vol .", "label": "", "metadata": {}, "score": "66.01633"}
{"text": "PubMed View Article .Slamon DJ , Clark GM , Wong SG , Levin WJ , Ullrich A , McGuire WL : Human breast cancer : correlation of relapse and survival with amplification of the HER-2/neu oncogene .", "label": "", "metadata": {}, "score": "66.034195"}
{"text": "PubMed View Article .Slamon DJ , Clark GM , Wong SG , Levin WJ , Ullrich A , McGuire WL : Human breast cancer : correlation of relapse and survival with amplification of the HER-2/neu oncogene .", "label": "", "metadata": {}, "score": "66.034195"}
{"text": "23 , pp .5323 - 5333 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. Frogne , R. V. Benjaminsen , K. Sonne - Hansen et al . , \" Activation of ErbB3 , EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant , \" Breast Cancer Research and Treatment , vol .", "label": "", "metadata": {}, "score": "66.1223"}
{"text": "HER2 amplification by dc - SISH was observed in 32 cases , with a mean ratio of 6.87 ( 95 % CI 5.51 to 8.23 ) and range 2.1 - 16.7 .", "label": "", "metadata": {}, "score": "66.12615"}
{"text": "12 , Article ID e29670 , 2011 .View at Publisher \u00b7 View at Google Scholar .S. Uchino , H. Tsuda , K. Maruyama et al . , \" Overexpression of c - erbB-2 protein in gastric cancer : its correlation with long - term survival of patients , \" Cancer , vol .", "label": "", "metadata": {}, "score": "66.14171"}
{"text": "G12V and TP53 p .Q317 , and 2 mutations in both TOP2A and RYR2 ( Figure 1 C ) .The HER2 -amplified patient with PDAC identified above clustered with the HER2 -amplified intrinsic subtype , with a confidence of 93 % .", "label": "", "metadata": {}, "score": "66.157455"}
{"text": "More recently , Ding and colleagues [ 35 ] demonstrated significant differences in hERG1 protein expression , according to factors such as serosal invasion , venous invasion , and TNM stage .", "label": "", "metadata": {}, "score": "66.199814"}
{"text": "Results .HER2 overexpression and clinicopathological characteristics .A total of 1,463 patients was evaluated by IHC analysis .The patients ' clinicopathological characteristics are listed in Table 1 .", "label": "", "metadata": {}, "score": "66.24657"}
{"text": "Our objective was to develop an automated brightfield double in situ hybridization ( BDISH ) application for HER2 gene and chromosome 17 centromere ( CEN 17 ) and test the assay performance with dual color HER2 FISH evaluated breast carcinomas .", "label": "", "metadata": {}, "score": "66.26913"}
{"text": "Samples scoring IHC 2 + were considered equivocal for HER2 overexpression .Fluorescence in situ hybridization .Fluorescence in situ hybridization ( FISH ) analysis was carried out with the PathVysion HER2 DNA probe kit and procedures ( Vysis / Abbott , Abbott Park , IL , USA ) .", "label": "", "metadata": {}, "score": "66.29859"}
{"text": "As indicated in Table 2 , there are four specimens that lack a PathVysion FISH result and two of these specimens are overlapping with HER2 CISH resulting in agreement calculations based on a total of 350 specimens for this comparison .", "label": "", "metadata": {}, "score": "66.31731"}
{"text": "PubMed .Marx AH , Tharun L , Muth J , Dancau AM , Simon R , Yekebas E , Kaifi JT , Mirlacher M , Brummendorf TH , Bokemeyer C : HER-2 amplification is highly homogenous in gastric cancer .", "label": "", "metadata": {}, "score": "66.3285"}
{"text": "Summary of studies reporting HER2 status in primary breast cancer and metastases .Gong et al .compared primary tumour with loco - regional and distant recurrence in 43 and 17 patients , respectively [ 12 ] .", "label": "", "metadata": {}, "score": "66.33205"}
{"text": "In conclusion , a thorough analysis of 1463 Chinese GC / GEJ cancer cases using FDA - approved reagents showed HER2 overexpression in 9.8 % of carcinomas , with a strong preference for GEJ location , intestinal cancer subtype , and well or moderately differentiated carcinomas .", "label": "", "metadata": {}, "score": "66.41641"}
{"text": "Discussion Accurate HER2 status testing is important for identifying breast cancer patients who may benefit from receiving trastuzumab therapy .Currently , in the United States , HER2 IHC methods are most commonly used for primary screening for HER2 status , and borderline cases are sub- jected to dual FISH for HER2 and CEN 17 to determine the HER2/CEN 17 ratio .", "label": "", "metadata": {}, "score": "66.4484"}
{"text": "Therefore , in cases with cluster amplification of blue signals additional caution should be taken during interpretation and results from other test methods such as IHC or FISH should be included before a final HER2 status is given .", "label": "", "metadata": {}, "score": "66.497444"}
{"text": "PubMed View Article .Shousha S , Peston D , Amo - Takyi B , Morgan M , Jasani B : Evaluation of automated silver - enhanced in situ hybridization ( SISH ) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens .", "label": "", "metadata": {}, "score": "66.51398"}
{"text": "PubMed View Article .Dandachi N , Dietze O , Hauser - Kronberger C : Chromogenic in situ hybridization : a novel approach to a practical and sensitive method for the detection of HER2 oncogene in archival human breast carcinoma .", "label": "", "metadata": {}, "score": "66.55951"}
{"text": "HER2 IHC staining shows weak to moderate complete , basolateral , or lateral membranous reactivity ( 2 + ) in tumor cells ( original magnification , \u00d7100 ) .", "label": "", "metadata": {}, "score": "66.60997"}
{"text": "No cases of heterogeneous HER2 amplification were detected in our study cohort , although two cases were noted to be heterogeneous with respect to the presence of polysomy .", "label": "", "metadata": {}, "score": "66.72325"}
{"text": "A positive association between HER2-positivity and intestinal - type cancers was identified in this and other studies [ 28 - 33 ] .In the ToGA trial , for example , countries with higher ratios of intestinal : diffuse / mixed cancer had increased HER2-positivity rates [ 23 ] .", "label": "", "metadata": {}, "score": "66.73257"}
{"text": "However , Ross et al .( 2009 ) [ 1 ] indicate that the true HER2 positivity rate probably is in the range 15 - 20 % , with national reference labs and community hospitals reporting lower rates and tertiary hospitals and cancer centers reporting slightly higher rates .", "label": "", "metadata": {}, "score": "66.806595"}
{"text": "Appl Immunohistochem Mol Morphol 2006 , 14:436 - 440 .Ciampa A , Xu B , Ayata G , Baiyee D , Wallace J , Wertheimer M , Edmis- ton K , Khan A : HER-2 status in breast cancer : correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system .", "label": "", "metadata": {}, "score": "66.84422"}
{"text": "Cancer cells were easily identified based on the tissue morphology and assess- ments of HER2/CEN 17 ratios could be readily conducted .Page 8 .", "label": "", "metadata": {}, "score": "66.86988"}
{"text": "The current study was undertaken to assess for the incidence of HER2 status of both primary and metastatic recurrence in patients from a single institution assessed in a high volume reference laboratory using uniform methodology , namely in - situ hybridization .", "label": "", "metadata": {}, "score": "66.97766"}
{"text": "Implementation of CISH for determination of HER2 amplification in breast cancer has some advantages compared to FISH based detection [ 6 - 9 ] .Chromogenic signals do not fade over time and can therefore be archived and used for re - evaluation or retrospective studies .", "label": "", "metadata": {}, "score": "67.11707"}
{"text": "105 - 112 , 2012 .View at Publisher \u00b7 View at Google Scholar . E. Lastraioli , L. Guasti , O. Crociani et al . , \" herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells , \" Cancer Research , vol .", "label": "", "metadata": {}, "score": "67.17273"}
{"text": "Then , the BDISH performance was evaluated with 94 routinely processed breast cancer tissues .Interpretation of HER2 and CEN 17 BDISH slides was conducted by 4 observers using a conventional brightfield microscope without oil immersion objectives .", "label": "", "metadata": {}, "score": "67.25867"}
{"text": "Because of unstable FISH staining characteristics , the signals of FISH slides can be bleached easily , even while reviewing and enumerating signals .Furthermore , digital images of the FISH slide need to be captured with a sensitive camera system for each patient case for the HER2 gene status record .", "label": "", "metadata": {}, "score": "67.39284"}
{"text": "In three of these five cases there was no remaining tissue to perform an appropriate RT - PCR analysis .For the last two cases the result of RT - PCR confirmed the HER2/ neu amplification shown by FISH and dc - SISH tests .", "label": "", "metadata": {}, "score": "67.535385"}
{"text": "The majority of patients ( 97.7 % ) had no distant metastases .Table 1 .The correlation between HER2 expression status and clinicopathological parameters .", "label": "", "metadata": {}, "score": "67.58081"}
{"text": "PubMed View Article .N Engl J Med 2001 , 344 : 783 - 792 .PubMed View Article .Aitken SJ , Thomas JS , Langdon SP , Harrison DJ , Faratian D : Quantitative analysis of changes in ER , PR and HER2 expression in primary breast cancer and paired nodal metastases .", "label": "", "metadata": {}, "score": "67.61546"}
{"text": "View at Google Scholar \u00b7 View at Scopus . E. Lastraioli , et al . , \" hERG1 channels are overexpressed in human gastric cancer and their activity regulates cell proliferation : a novel prognostic and therapeutic target ? \" in Proceedings of the 6th IGCC , pp .", "label": "", "metadata": {}, "score": "67.66257"}
{"text": "During the study , ADCC was measured ex - vivo in peripheral blood mononuclear cells ( PBMCs ) and showed enhanced activity of margetuximab v. trastuzumab .", "label": "", "metadata": {}, "score": "67.69277"}
{"text": "Dowsett M , Hanby AM , Laing R , Walker R , National HER2 Consulta- tion Steering Group : HER2 testing in the UK : consensus from a national consultation .", "label": "", "metadata": {}, "score": "67.77909"}
{"text": "View Article .Hofmann M , Stoss O , Shi D , Buttner R , van de Vijver M , Kim W , Ochiai A , Ruschoff J , Henkel T : Assessment of a HER2 scoring system for gastric cancer : results from a validation study .", "label": "", "metadata": {}, "score": "67.78375"}
{"text": "BT-474 cell line presents HER2 amplification with 50 - 60 copies of HER2 genes and 4 - 6 copies of CEN 17 per nucleus [ 29]. Ampli-", "label": "", "metadata": {}, "score": "67.81779"}
{"text": "PubMed View Article .Kunz PL , Mojtahed A , Fisher GA , Ford JM , Chang DT , Balise RR , Bangs CD , Cherry AM , Pai RK : HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population : clinicopathologic analysis with proposed approach to HER2 assessment .", "label": "", "metadata": {}, "score": "67.92817"}
{"text": "Methods .HER2 amplification was detected and further analyzed using multiple genomic sequencing approaches .Results .An amplified inversion event ( 1 MB ) was identified at the HER2 locus in a patient with PDAC .", "label": "", "metadata": {}, "score": "67.93799"}
{"text": "About Breast Cancer and HER2 .The HER2 oncoprotein is over - expressed and plays an important role in tumorigenesis , tumor aggressiveness , and outcome in breast cancer and other solid tumors .", "label": "", "metadata": {}, "score": "67.9763"}
{"text": "PubMed View Article .Tafe LJ , Janjigian YY , Zaidinski M , Hedvat CV , Hameed MR , Tang LH , Hicks JB , Shah MA , Barbashina V : Human epidermal growth factor receptor 2 testing in gastroesophageal cancer : correlation between immunohistochemistry and fluorescence in situ hybridization .", "label": "", "metadata": {}, "score": "68.0211"}
{"text": "487 - 493 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Tanner , M. Hollm\u00e9n , T. T. Junttila et al . , \" Amplification of HER-2 in gastric carcinoma : association with Topoisomerase II \u03b1 gene amplification , intestinal type , poor prognosis and sensitivity to trastuzumab , \" Annals of Oncology , vol .", "label": "", "metadata": {}, "score": "68.04251"}
{"text": "PubMed View Article .Ann Oncol 2009 , 20 : 1953 - 1958 .PubMed View Article .Solomayer EF , Becker S , Pergola - Becker G , Bachmann R , Kramer B , Vogel U , Neubauer H , Wallwiener D , Huober J , Fehm TN : Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients .", "label": "", "metadata": {}, "score": "68.06069"}
{"text": "View at Publisher \u00b7 View at Google Scholar .L. Bianchi , B. Wible , A. Arcangeli et al . , \" herg encodes a K+ current highly conserved in tumors of different histogenesis : a selective advantage for cancer cells ? \"", "label": "", "metadata": {}, "score": "68.08269"}
{"text": "Relationship between pathological features , HER2 protein expression and HER2 and CEP17 copy number in breast cancer : biological and methodological considerations .JOURNAL OF CLINICAL PATHOLOGY , 64 ( 3 ) , 200 - 207 .", "label": "", "metadata": {}, "score": "68.102264"}
{"text": "Surprisingly , average copy numbers for both HER2 and CEN-17 were higher for the HER2 CISH method , whereas , HER2 CISH standard deviations seemed to be lower for the average HER2 /CEN-17 ratio , HER2 and CEN-17 copy numbers compared to PathVysion FISH .", "label": "", "metadata": {}, "score": "68.20448"}
{"text": "PubMed View Article .Clin Cancer Res 2009 , 15 : 7381 - 7388 .PubMed View Article .Vincent - Salomon A , Jouve M , Genin P , Freneaux P , Sigal - Zafrani B , Caly M , Beuzeboc P , Pouillart P , Sastre - Garau X : HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process .", "label": "", "metadata": {}, "score": "68.20935"}
{"text": "Recently standardized scoring criteria for GC and GEJ cancer has been established and recommended .In this study , the frequency of HER2 expression and the relationship between HER2 expression and clinicopathological features were examined in a large cohort of Chinese GC and GEJ cancer patients .", "label": "", "metadata": {}, "score": "68.2161"}
{"text": "11 , pp .1659 - 1665 , 2010 .View at Google Scholar \u00b7 View at Scopus .S. M\u00e9nard , E. Tagliabue , M. Campiglio , and S. M. Pupa , \" Role of HER2 gene overexpression in breast carcinoma , \" Journal of Cellular Physiology , vol .", "label": "", "metadata": {}, "score": "68.25615"}
{"text": "Lambein K , Praet M , Forsyth R , Van den Broecke R , Braems G , MATTHYS B , et al .Relationship between pathological features , HER2 protein expression and HER2 and CEP17 copy number in breast cancer : biological and methodological considerations .", "label": "", "metadata": {}, "score": "68.30522"}
{"text": "HER2 gene status frequencies of successful test results divided by assay .Images of specimens stained with HER2 CISH pharmDx \u2122 Kit .HER2 status agreement .", "label": "", "metadata": {}, "score": "68.329346"}
{"text": "HER2 Concordance rates .Local evaluation of the primary and recurrent lesion by IHC is shown in Table 3 , with 78 % concordance between the paired samples when categorising as negative ( 0 or 1 + ) , inconclusive ( 2 + ) or positive ( 3 + ) .", "label": "", "metadata": {}, "score": "68.33109"}
{"text": "To implement CISH in the anatomical pathological laboratories for determination of HER2 status in breast cancer the technique needs to be safe and reliable [ 10 ] .", "label": "", "metadata": {}, "score": "68.3374"}
{"text": "Am J Surg Pathol 2005 , 29:1505 - 1511 .Powell RD , Pettay JD , Powell WC , Roche PC , Grogan TM , Hainfeld JF , Tubbs RR : Metallographic in situ hybridization .", "label": "", "metadata": {}, "score": "68.338135"}
{"text": "Ross JS , Symmans WF , Pusztai L , Hortobagyi GN : Standardizing slide - based assays in breast cancer : hormone receptors , HER2 , and sentinel lymph nodes .", "label": "", "metadata": {}, "score": "68.36822"}
{"text": "MCF7 is a breast adenocarci- noma cell line with non - amplified HER2 status and BT- 474 is a breast ductal carcinoma with amplified HER2 sta- tus ( 50 - 60 copies of HER2 ) and chromosome 17 polys- omy [ 29].", "label": "", "metadata": {}, "score": "68.45558"}
{"text": "Detection of HER2 and CEN 17 signals was accomplished with the silver acetate , hydroquinone , and H2O2 reaction with horseradish peroxidase ( HRP ) and the fast red and naphthol phosphate reaction with alkaline phosphatise ( AP ) , respectively .", "label": "", "metadata": {}, "score": "68.474884"}
{"text": "View at Google Scholar .T. Nakao , N. Kurita , M. Komatsu et al . , \" Expression of thrombospondin-1 and Ski are prognostic factors in advanced gastric cancer , \" International Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "68.48381"}
{"text": "Subtle HER2 genetic heterogeneity of tumor cells has been reported among equivocal cases [ 17,19].An alternative method for determining HER2 status from FFPE breast cancer samples based on the quantitative reverse transcription - polymerase chain reaction ( qRT - PCR ) has been proposed , but has not been approved by the FDA . \" The HER2 gene - protein assay was optimized using formalin - fixed , paraffin - embedded ( FFPE ) samples of the xenograft tumors MCF7 [ HER2 negative ( non - amplified gene , protein negative ) ] and Calu-3 [ HER2 positive ( amplified gene , protein positive)].", "label": "", "metadata": {}, "score": "68.49129"}
{"text": "No correlation was observed between HER2 overexpressed and not overexpressed cases in terms of age , sex , pT , N , M factors , or pathologic TNM stage .", "label": "", "metadata": {}, "score": "68.536804"}
{"text": "HER2 and CEN 17 copy numbers have been doc- umented previously using the FISH assay [ 29].Examples of normal HER2 gene ( A ) , amplified HER2 gene ( B ) , single HER2 gene ( C ) , and chromosome 17 polysomy ( D ) cases were shown .", "label": "", "metadata": {}, "score": "68.58255"}
{"text": "Page 5 .Single or double stained tissue sections for HER2 and/or CEN 17 targets were counterstained with Hematoxylin II ( Ventana ) for 4 or 8 minutes and Bluing Reagent ( Ven- tana ) for 4 minutes .", "label": "", "metadata": {}, "score": "68.60722"}
{"text": "PubMed View Article .Ross JS , Fletcher JA , Bloom KJ , Linette GP , Stec J , Symmans WF , Pusztai L , Hortobagyi GN : Targeted therapy in breast cancer : the HER-2/neu gene and protein .", "label": "", "metadata": {}, "score": "68.70189"}
{"text": "Recurrent samples included fine needle aspirations , core and excisional biopsies .HER2 status in all paired samples was assessed by in - situ hybridisation by a single pathologist in a national reference laboratory .", "label": "", "metadata": {}, "score": "68.80066"}
{"text": "1238 - 1250 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Lastraioli , L. Bencini , E. Bianchini et al . , \" hERG1 channels and Glut-1 as independent prognostic indicators of worse outcome in stage I and II colorectal cancer : a pilot study , \" Translational Oncology , vol .", "label": "", "metadata": {}, "score": "68.81099"}
{"text": "This pathway has been evaluated in preclinical and early clinical settings of GC .From the very early studies , MET expression has been recognized as an important poor prognostic marker in GC .", "label": "", "metadata": {}, "score": "68.846375"}
{"text": "11 , pp .1460 - 1465 , 2011 .View at Publisher \u00b7 View at Google Scholar . Y. S. Park , H. S. Hwang , H. J. Park et al . , \" Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization : which scoring system should we use ? \"", "label": "", "metadata": {}, "score": "68.99344"}
{"text": "399 - 405 , 2012 .View at Publisher \u00b7 View at Google Scholar .J. D. Barros - Silva , et al . , \" Association of ERBB2 gene status with histopathological parameters and disease - specific survival in gastric carcinoma patients , \" British Journal of Cancer , vol .", "label": "", "metadata": {}, "score": "69.00587"}
{"text": "161 - 166 , 2011 .View at Publisher \u00b7 View at Google Scholar .M. K. Kwak , H.-J. Lee , K. Hur et al . , \" Expression of Kr\u00fcppel - like factor 5 in human gastric carcinomas , \" Journal of Cancer Research and Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "69.04832"}
{"text": "Study design .This is a retrospective , single center study , aimed to investigate the rate of HER2 neu discordance between primary breast carcinoma and locoregional or metastatic disease in patients seen by a single clinician at the Mount Hospital between 1999 and 2009 .", "label": "", "metadata": {}, "score": "69.11119"}
{"text": "In order to evaluate HER2 CISH assay performance closer to the cut - off this data were also presented for all valid specimens having a CISH HER2 /CEN-17 ratio below 3.0 ( Table 6 ) .", "label": "", "metadata": {}, "score": "69.11926"}
{"text": "There are alternatives to FISH for determining HER2 gene status .The chromogenic in situ hybridization ( CISH ) assay using a DAB chromogen and H2O2 substrate system for horseradish peroxidase ( HRP)-based signal detection has been evaluated and the value of this assay for assess- ing HER2 status has been demonstrated [ 12,17 - 22].", "label": "", "metadata": {}, "score": "69.175095"}
{"text": "References 1 .Yaziji H , Goldstein LC , Barry TS , Werling R , Hwang H , Ellis GK , Gralow JR , Livingston RB , Gown AM : HER-2 testing in breast can- cer using parallel tissue - based methods .", "label": "", "metadata": {}, "score": "69.20255"}
{"text": "However the optimal HER2 testing strategy has not been defined yet .Due to the recent approval of trastuzumab for HER2-positive GC in Europe , HER2 diagnostics is now mandatory : IHC is used as primary test , and it is followed by fluorescence in situ hybridization ( FISH ) in IHC2 + cases [ 27 ] .", "label": "", "metadata": {}, "score": "69.24848"}
{"text": "The strength of this study was uniform use of silver in situ hybridisation ( SISH ) for assessment of the paired samples .A further finding in this group was the significant increase in gene copy number in the metastases of tumours that were amplified in the primary lesion as defined by SISH [ 14 ] .", "label": "", "metadata": {}, "score": "69.26657"}
{"text": "Tubbs R , Pettay J , Skacel M , Powell R , Stoler M , Roche P , Hainfeld J : Gold facilitated in situ hybridization ( GOLDFISH ) : A bright field autometallographic alternative to fluorescence in situ hybridization for detection of HER-2/neu gene amplification .", "label": "", "metadata": {}, "score": "69.28811"}
{"text": "Recruiting patients based on HER2 amplification rather than organ of tumour origin would make trials of anti - HER2 therapies feasible in less common cancer types .", "label": "", "metadata": {}, "score": "69.3039"}
{"text": "A .HER2 IHC staining shows complete , basolateral , or lateral membranous reactivity of strong intensity ( 3 + ) in tumor cells ( original magnification , \u00d740 ) .", "label": "", "metadata": {}, "score": "69.30952"}
{"text": "In particular , VEGF - A expression seems to be a negative prognostic factor , at least in EGCs [ 80 ] .Moreover , VEGF - A expression has been proven to be relevant to therapeutic response in GC patients treated with fluorouracil alone or together with cisplatin [ 81 ] .", "label": "", "metadata": {}, "score": "69.344025"}
{"text": "Dowsett M , Hanna WM , Kockx M , Penault - Llorca F , R\u00fcschoff J , Gut- jahr T , Habben K , Vijver MJ van de : Standardization of HER2 test- ing : results of an international proficiency - testing ring study .", "label": "", "metadata": {}, "score": "69.37048"}
{"text": "Approximately 10 % of Chinese patients with primary GC and GEJ adenocarcinoma were HER2-positive on IHC .HER2 overexpression was associated with GEJ site , intestinal cancer subtype , and well or moderately differentiated carcinomas .", "label": "", "metadata": {}, "score": "69.38231"}
{"text": "Approximately 10 % of Chinese patients with primary GC and GEJ adenocarcinoma were HER2-positive on IHC .HER2 overexpression was associated with GEJ site , intestinal cancer subtype , and well or moderately differentiated carcinomas .", "label": "", "metadata": {}, "score": "69.38231"}
{"text": "In particular , hERG1 activity is modulated by hypoxia [ 94 ] and regulates VEGF - A secretion in astrocytomas [ 84 ] .In addition , hERG1 channels mediate VEGF - Receptor-1 ( FLT-1)-induced cell migration and signalling in acute myeloid leukemias [ 90 ] . hERG1 is also overexpressed in cancers of the gastrointestinal tract , in particular in colorectal [ 91 , 92 ] and oesophageal adenocarcinomas [ 93 ] .", "label": "", "metadata": {}, "score": "69.428505"}
{"text": "HER2 immunohistochemistry ( IHC ) and in situ hybridization ( ISH ) was performed in a national reference HER2 diagnostic testing laboratory .Scoring for HER2 protein expression and amplification was based on criteria recommended for breast and gastric carcinoma ( Table 1 ) [ 21 ] .", "label": "", "metadata": {}, "score": "69.46689"}
{"text": "HER2 status .IHC testing .All specimens were tested at the US reference laboratory using HercepTest \u2122 as per the manufacturer 's instructions to determine the IHC HER2 score .", "label": "", "metadata": {}, "score": "69.50094"}
{"text": "The BDISH specificity was optimized with formalin - fixed , paraffin - embedded xenograft tumors , MCF7 ( non - amplified HER2 gene ) and BT-474 ( amplified HER2 gene ) .", "label": "", "metadata": {}, "score": "69.5334"}
{"text": "PubMed View Article .Kataoka Y , Okabe H , Yoshizawa A , Minamiguchi S , Yoshimura K , Haga H , Sakai Y : HER2 expression and its clinicopathological features in resectable gastric cancer .", "label": "", "metadata": {}, "score": "69.545006"}
{"text": "Emerging data from cancer sequencing initiatives such as the International Cancer Genome Consortium ( ICGC )[ 6 ] and The Cancer Genome Atlas ( TCGA ) [ 7 ] are unveiling a vast heterogeneity of molecular aberrations in cancer .", "label": "", "metadata": {}, "score": "69.62363"}
{"text": "It is interesting to note that all three HER2 -amplified cases with available genomic data harboured the KRASp .G12V mutation .This mutation is less common than the p .", "label": "", "metadata": {}, "score": "69.643875"}
{"text": "In HER2 CISH a higher number of specimens were reported failed in comparison to staining with PathVysion FISH .This is likely to be due to CISH being a new technique implemented in the US reference laboratory and PathVysion FISH being a well established test method at this site .", "label": "", "metadata": {}, "score": "69.67067"}
{"text": "The concordance between results obtained using the recently FDA approved HER2 CISH pharmDx \u2122 Kit with previously FDA approved FISH techniques for HER2 gene status determination indicate that the HER2 CISH pharmDx \u2122 Kit is a reliable chromogenic alternative to fluorescence - based methods .", "label": "", "metadata": {}, "score": "69.67352"}
{"text": "The study was approved by the Mount Hospital Ethics and Research Committee and conducted in accordance with the Helsinki declaration .Study population .The study population comprised those patients who had adequate tissue available from paired primary and recurrent tumour samples for assessment of HER2 amplification .", "label": "", "metadata": {}, "score": "69.68509"}
{"text": "Using this method , HER2 status testing can be conducted in a simplified manner for more accurately identifying the patients who are eligible for trastuzumab therapy and potentially leading to the improvement of breast cancer patient care in the future .", "label": "", "metadata": {}, "score": "69.774574"}
{"text": "977 - 985 , 2012 .View at Google Scholar .C. Cheng , X. Lu , G. Wang et al . , \" Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features , \" Acta Pathologica , Microbiologica et Immunologica Scandinavica , vol .", "label": "", "metadata": {}, "score": "69.78046"}
{"text": "Since the data showed heteroscedasticity with apparent elevated variances at higher ratios linear regression was not carried out .The plots of HER2 /CEN-17 ratios in Figure 2 and Figure 3 also reveal that lower HER2 CISH ratios are observed at ratios above 3.0 compared to ratios obtained by FISH .", "label": "", "metadata": {}, "score": "69.798935"}
{"text": "HER2 IHC assays can be performed using an automated slide staining system , but HER2 FISH assays remain tech- nically challenging and time consuming manual molecu- lar diagnostic assays in most laboratories .", "label": "", "metadata": {}, "score": "69.80159"}
{"text": "View Article .Zhang XL , Yang YS , Xu DP , Qu JH , Guo MZ , Gong Y , Huang J : Comparative study on overexpression of HER2/neu and HER3 in gastric cancer .", "label": "", "metadata": {}, "score": "69.831406"}
{"text": "Stevens R , Almanaseer I , Gonzalez M , Caglar D , Knudson RA , Ketter- ling RP , Schrock DS , Seemayer TA , Bridge JA : Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system .", "label": "", "metadata": {}, "score": "69.92537"}
{"text": "45 - 50 , 2008 .View at Google Scholar \u00b7 View at Scopus Aims A few reports have assessed HER2 status in breast cancer by both dual - probe fluorescence in situ hybridisation ( FISH ) and immunohistochemistry ( IHC ) in an unselected and consecutive fashion , but CEP17 and HER2 copy number were not evaluated separately in these studies .", "label": "", "metadata": {}, "score": "70.011"}
{"text": "Figure 1 includes images illustrating a non - amplified and a cluster amplified breast cancer specimen stained by HER2 CISH pharmDx \u2122 Kit .In both panels tumor cells having distinctive blue dots are observed corresponding to the reference CEN-17 probe signals ( Figure 1 ) .", "label": "", "metadata": {}, "score": "70.02703"}
{"text": "J Pathol 2006 , 210:3 - 9 .Diagn Mol Pathol 2007 , 16:207 - 210 .Tuma RS : Inconsistency of HER2 test raises questions .", "label": "", "metadata": {}, "score": "70.052216"}
{"text": "A GC case without HER2 amplification using FISH analysis .Concordance of HER2 IHC and FISH .Table 2 .Correlation between HER2 overexpression and gene amplification in GC and GEJ adenocarcinoma .", "label": "", "metadata": {}, "score": "70.08363"}
{"text": "Giotta F , Simone G , Fazio V , Longo S , Petroni S , Rubini V , Liuzzi M , Addati T , Colucci G : Patterns of HER2/neu , hormonal receptor expression , and proliferative activity in primary and metastatic breast cancer .", "label": "", "metadata": {}, "score": "70.09555"}
{"text": "The metallic silver deposit for HER2 ISH signal was developed using silver acetate , hydroquinone , and H2O2 reaction in the presence of HRP using the ultraView \u2122 SISH Detection Kit ( Ven- tana ) .", "label": "", "metadata": {}, "score": "70.22516"}
{"text": "Only 3 of 27 cases that were Her2 2 + on IHC were found to be HER2 -amplified ( 11 % ) .No cases of 1 + or negative Her2 IHC were HER2 -amplified , and the overall prevalence of HER2 amplification was 2.1 % ( 10 of 469 cases ) .", "label": "", "metadata": {}, "score": "70.277794"}
{"text": "11 , pp .3179 - 3184 , 1993 .View at Publisher \u00b7 View at Google Scholar .M. Nakajima , H. Sawada , Y. Yamada et al . , \" The prognostic significance of amplification and overexpression of c- met and c - erb B-2 in human gastric carcinomas , \" Cancer , vol . 85 , no . 9 , pp .", "label": "", "metadata": {}, "score": "70.278595"}
{"text": "The remaining patients had nodal metastases in which some showed HER2 concordance with the primary tumour , illustrating the heterogeneity that may exist [ 15 ] .", "label": "", "metadata": {}, "score": "70.29773"}
{"text": "Page 3 .However , with the current CISH method , the assessment of the HER2/CEN 17 ratio is con- ducted by enumerating HER2 and CEN 17 separately using two different tissue sections .", "label": "", "metadata": {}, "score": "70.30017"}
{"text": "Conclusions .This single institution study demonstrated a low rate of HER2 discordance between primary and recurrent breast cancer as assessed by in - situ hybridisation .", "label": "", "metadata": {}, "score": "70.306366"}
{"text": "View Article .Kato N , Itoh H , Serizawa A , Hatanaka Y , Umemura S , Osamura RY : Evaluation of HER2 gene amplification in invasive breast cancer using a dual - color chromogenic in situ hybridization ( dual CISH ) .", "label": "", "metadata": {}, "score": "70.34242"}
{"text": "PubMed View Article .Hoff K , Jorgensen JT , Muller S , Rongaard E , Rasmussen O , Schonau A : Visualization of FISH Probes by dual - color chromogenic in situ hybridization .", "label": "", "metadata": {}, "score": "70.34479"}
{"text": "Table 1 summarizes HER2 expression status by subgroup .HER2 was overexpressed ( score 3 + ) in 7.0 % ( 65/929 ) of GC cases and 14.6 % ( 78/534 ) of GEJ adenocarcinoma cases ( Figure 1 A ) .", "label": "", "metadata": {}, "score": "70.3811"}
{"text": "In addition , there is a minor subjectivity in the interpretation of results with the hybridisation techniques compared with the IHC method , for which three different criteria have been developed in the last 3 years .", "label": "", "metadata": {}, "score": "70.41534"}
{"text": "PubMed View Article .Choi JH , Han HS , Lee HC , Lee OJ , Kim JT , Lim SN , Lee KH , Kim ST : Positive response to trastuzumab in a case of HER2-overexpressing metastatic gastric cancer that presented as severe thrombocytopenia .", "label": "", "metadata": {}, "score": "70.41871"}
{"text": "549 - 558 , 2010 .View at Google Scholar .C. C. Schimanski , F. Schlaegel , M. Jordan et al . , \" VEGF - D correlates with metastatic disease in gastric cancer patients undergoing surgery , \" World Journal of Surgery , vol .", "label": "", "metadata": {}, "score": "70.42728"}
{"text": "237 - 241 , 2012 .View at Publisher \u00b7 View at Google Scholar . D. I. Park , J. W. Yun , J. H. Park et al . , \" HER-2/neu amplification is an independent prognostic factor in gastric cancer , \" Digestive Diseases and Sciences , vol .", "label": "", "metadata": {}, "score": "70.44832"}
{"text": "Gong Y , Booser DJ , Sneige N : Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma .", "label": "", "metadata": {}, "score": "70.5311"}
{"text": "In one study , when the FISH assay was used as the primary test for HER2 status assessment of breast carcinoma cases , heterogeneity of HER2 gene status was observed in 40 of 742 cases ( 5 % ) [ 43].", "label": "", "metadata": {}, "score": "70.67284"}
{"text": "Further , it is established that the benefit of anti - HER2 therapy is largely achieved in those patients whose tumours are confirmed as being positive , either by 3 + HER2 protein expression on immunohistochemistry ( IHC ) or gene amplification by in - situ hybridization ( ISH ) .", "label": "", "metadata": {}, "score": "70.69977"}
{"text": "The optimal scoring method for determina- tion of HER2 gene status is the use of chromosome 17 centromere ( CEN 17 ) enumeration for calculating the HER2/CEN 17 ratio [ 9].", "label": "", "metadata": {}, "score": "70.72409"}
{"text": "Because of the size difference and color contrast of black dots for HER2 gene and red dots for CEN 17 , they could be visu- ally separated even when red and black signals were co- .", "label": "", "metadata": {}, "score": "70.74868"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. H. Morals Cabral , A. Lee , S. L. Cohen , B. T. Chait , M. Li , and R. Mackinnon , \" Crystal structure and functional analysis of the HERG potassium channel N terminus : a eukaryotic PAS domain , \" Cell , vol .", "label": "", "metadata": {}, "score": "70.75354"}
{"text": "Abstract .Background .Overall survival of HER2 positive metastatic breast cancer patients has been significantly improved with inclusion of trastuzumab to chemotherapy .Several studies have demonstrated discordant HER2 status in the primary and metastatic tumour .", "label": "", "metadata": {}, "score": "70.76233"}
{"text": "Automated BDISH applications for HER2 and CEN 17 targets were successfully developed and it might be able to replace manual two - color HER2 FISH methods .", "label": "", "metadata": {}, "score": "70.78977"}
{"text": "IHC score frequencies of specimens included for the entire population studied including specimens sampled consecutively .Frequencies of amplified and non - amplified specimens .Frequencies of HER2 amplified and non - amplified test results found by HER2 CISH , HER2 FISH and PathVysion FISH are presented in Table 2 for all specimens .", "label": "", "metadata": {}, "score": "70.84908"}
{"text": "Hypoxia within tumor mass induces VEGF - A secretion and increased VEGFR-2 expression [ 76 ] .It has been demonstrated that VEGF - A expression is higher in I - GC compared to D - GC [ 32 ] .", "label": "", "metadata": {}, "score": "70.856186"}
{"text": "HER2 Metastatic breast cancer Discordance .Background .Optimal management of metastatic breast cancer requires accurate identification of the biological characteristics of the recurrent disease .", "label": "", "metadata": {}, "score": "70.90462"}
{"text": "606 - 611 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Lastraioli , A. Taddei , L. Messerini et al . , \" hERG1 channels in human esophagus : evidence for their aberrant expression in the malignant progression of Barrett 's esophagus , \" Journal of Cellular Physiology , vol .", "label": "", "metadata": {}, "score": "70.91087"}
{"text": "781 - 792 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Jehle , P. A. Schweizer , H. A. Katus , and D. Thomas , \" Novel roles for hERG K + channels in cell proliferation and apoptosis , \" Cell Death and Disease , vol .", "label": "", "metadata": {}, "score": "70.96718"}
{"text": "PubMed View Article .Barros - Silva JD , Leitao D , Afonso L , Vieira J , Dinis - Ribeiro M , Fragoso M , Bento MJ , Santos L , Ferreira P , Rego S : Association of ERBB2 gene status with histopathological parameters and disease - specific survival in gastric carcinoma patients .", "label": "", "metadata": {}, "score": "70.98568"}
{"text": "Thus , the SISH detection and the fast red detection can be combined to perform a sequential double ISH assay with 2 probes labeled with the same hapten .", "label": "", "metadata": {}, "score": "71.028885"}
{"text": "Pretreatment conditions were chosen for optimal signal to noise ratio and tissue morphology preservation for the xenograft control slides as well as clinical case tis- sue slides .", "label": "", "metadata": {}, "score": "71.09462"}
{"text": "View Article .Ruschoff J , Dietel M , Baretton G , Arbogast S , Walch A , Monges G , Chenard MP , Penault - Llorca F , Nagelmeier I , Schlake W : HER2 diagnostics in gastric cancer - guideline validation and development of standardized immunohistochemical testing .", "label": "", "metadata": {}, "score": "71.17563"}
{"text": "Fluorescence in situ hybridization ( FISH ) analysis was used in 308 GCs and GEJ adenocarcinoma cases to assess HER2 gene amplification .HER2 equivocal ( 2 + ) was detected in 14.4 % of cases .", "label": "", "metadata": {}, "score": "71.21506"}
{"text": "58 , no .4 , pp .815 - 822 , 1998 .View at Google Scholar \u00b7 View at Scopus . A. Cherubini , G. L. Taddei , O. Crociani et al . , \" HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non - cancerous endometrium , \" British Journal of Cancer , vol .", "label": "", "metadata": {}, "score": "71.257904"}
{"text": "Interestingly , a similar conclusion has been reached in breast carcinomas and proposed in gastric carcinoma , given the inconsistencies in HER2 IHC testing .22 - 24 In this regard , a comprehensive analysis of some of the ToGA subgroups would be most valuable in providing robust guidelines for HER2 testing .", "label": "", "metadata": {}, "score": "71.29583"}
{"text": "4 , no . 2 , pp .62 - 66 , 2011 .View at Google Scholar .J. R\u00fcschoff , M. Dietel , G. Baretton et al . , \" HER2 diagnostics in gastric cancer - guideline validation and development of standardized immunohistochemical testing , \" Virchows Archiv , vol .", "label": "", "metadata": {}, "score": "71.30241"}
{"text": "PubMed View Article .Smith I , Procter M , Gelber RD , Guillaume S , Feyereislova A , Dowsett M , Goldhirsch A , Untch M , Mariani G , Baselga J : 2-year follow - up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer : a randomised controlled trial .", "label": "", "metadata": {}, "score": "71.306984"}
{"text": "CISH testing .HER2 CISH staining was performed according to the manufactures instructions ( Dako Denmark A / S ) at the US reference laboratory .", "label": "", "metadata": {}, "score": "71.3611"}
{"text": "Methods .Here it is reported from a comparative study where HER2 gene status obtained by HER2 CISH pharmDx \u2122 Kit was compared to HER2 gene status obtained by the FDA approved HER2 FISH pharmDx \u2122 Kit and the PathVysion HER-2 DNA probe Kit .", "label": "", "metadata": {}, "score": "71.379166"}
{"text": "Clinicopathological data are detailed in table 1 .Frequency of HER2 gene amplification or overexpression .HER2 amplification by FISH obtained 27 cases of HER2 oncogen amplification .", "label": "", "metadata": {}, "score": "71.39487"}
{"text": "Briefly , samples focused on primary operable non - pretreated PDAC .Nucleic acids were extracted from fresh frozen tumour and normal tissue pairs , and whole genome and exome sequencing was performed using a combination of long mate pair and paired - end approaches .", "label": "", "metadata": {}, "score": "71.43282"}
{"text": "HER2 ( Human Epidermal Growth Factor Receptor 2 ) is an important marker for invasive breast cancer .The assessment of the HER2 expression level is routinely done by examining protein expression and/or gene expression levels in formalin - fixed and paraffin - embedded ( FFPE ) histological sections .", "label": "", "metadata": {}, "score": "71.436356"}
{"text": "For CEN 17 ISH , we have opti- mized a new detection system with an alkaline phos- phatase - conjugated antibody and fast red chromogen and naphthol phosphate substrate reaction .", "label": "", "metadata": {}, "score": "71.441956"}
{"text": "4905 , pp .707 - 712 , 1989 .View at Google Scholar \u00b7 View at Scopus .G. Giuffr\u00e8 , A. Ieni , V. Barresi , R. A. Caruso , and G. Tuccari , \" HER2 status in unusual histological variants of gastric adenocarcinomas , \" Journal of Clinical Pathology , vol .", "label": "", "metadata": {}, "score": "71.47707"}
{"text": "The prognostic value of the HER2 protein expression in GC is a controversial topic .5 - 7 Although in most studies HER2 overexpression and/or amplification has been considered a poor prognosis factor , 8 , 9 recent studies appear to cast doubt on this negative view particularly after the results of the ToGA ( Trastuzumab for Gastric Cancer ) study .", "label": "", "metadata": {}, "score": "71.48605"}
{"text": "150 - 162 , 2000 .View at Publisher \u00b7 View at Google Scholar .D. J. Slamon , W. Godolphin , L. A. Jones et al . , \" Studies of the HER-2/neu proto - oncogene in human breast and ovarian cancer , \" Science , vol .", "label": "", "metadata": {}, "score": "71.587006"}
{"text": "The latter then transmit signals to different downstream cascades , including the MAPK and the PI3K / AKT pathways [ 16 , 18 ] .", "label": "", "metadata": {}, "score": "71.60257"}
{"text": "HER2 gene amplification and protein overexpression , which occur in 20 % to 25 % of breast cancer patients , have been recognized as prognostic and predictive markers for treatment [ 4 ] .", "label": "", "metadata": {}, "score": "71.610176"}
{"text": "HER2 gene amplification and protein overexpression , which occur in 20 % to 25 % of breast cancer patients , have been recognized as prognostic and predictive markers for treatment [ 4].", "label": "", "metadata": {}, "score": "71.610176"}
{"text": "PubMed View Article .Buchler P , Reber HA , Buchler MC , Roth MA , B\u00fcchler MW , Friess H , Isacoff WH , Hines OJ : Therapy for pancreatic cancer with a recombinant humanized anti - HER2 antibody ( herceptin ) .", "label": "", "metadata": {}, "score": "71.612305"}
{"text": "PubMed View Article .Lindstrom L , Karlsson E , Wilking U , et al .: Clinically used breast cancer markers such as estrogen receptor , progesterone receptor , and human epidermal growth factor receptor 2 are unstable throughout tumor progression .", "label": "", "metadata": {}, "score": "71.679375"}
{"text": "However , current HER2 FISH procedures are labor intensive , manual methods that require skilled technologists and specialized fluorescence microscopy .Furthermore , FISH slides can not be archived for long term storage and review .", "label": "", "metadata": {}, "score": "71.68118"}
{"text": "View Article .Grabsch H , Sivakumar S , Gray S , Gabbert HE , Muller W : HER2 expression in gastric cancer : Rare , heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series .", "label": "", "metadata": {}, "score": "71.7452"}
{"text": "BHW and ML were responsible for the final assay develop- ment .AEM conducted all statistical analyses for the per- formance of BDISH assay .FG was the study coordinator and contributed intellectual content of the study .", "label": "", "metadata": {}, "score": "71.80585"}
{"text": "The signals from the fluorescent probes were converted to chromogenic signals in an IHC staining reaction performed on an automated platform ( Autostainer Plus , Dako Denmark A / S ) .", "label": "", "metadata": {}, "score": "71.82779"}
{"text": "The use of BDISH technology allows the simultaneous analyses of two DNA targets within the context of tissue morphological observation .Full - text .However , current HER2 FISH procedures are labor intensive , manual methods that require skilled technologists and specialized fluorescence microscopy .", "label": "", "metadata": {}, "score": "71.83936"}
{"text": "In prior research , margetuximab showed improved control of tumor growth in human tumor xenograft models in mice , as compared to that of anti - HER2 antibodies with a wild type Fc counterpart and in effector cell - dependent ADCC assays .", "label": "", "metadata": {}, "score": "71.8454"}
{"text": "PubMed View Article .Clin Transl Oncol 2011 , 13 ( 3 ) : 179 - 184 .PubMed View Article .Shitara K , Mizota A , Yatabe Y , Kondo C , Nomura M , Yokota T , Takahari D , Ura T , Muro K : Lapatinib plus trastuzumab for a patient with heavily pre - treated gastric cancer that progressed after trastuzumab .", "label": "", "metadata": {}, "score": "71.84769"}
{"text": "Therefore HER2 status was reliably assessed in the primary with 97 % concordance and it was considered that the HER2 status remained stable during the metastatic process [ 12 ] .", "label": "", "metadata": {}, "score": "71.8846"}
{"text": "HER2 was negative ( 1+/0 ) in 80.0 % ( 743/929 ) of GC cases and 68.5 % ( 366/534 ) of GEJ adenocarcinoma samples ( Figure 1 C and D ) .", "label": "", "metadata": {}, "score": "72.06019"}
{"text": "HER2 immunohistochemistry scores of specimens included .A total of 365 breast cancer specimens were included in this investigation .An overview of the HER2 IHC scores obtained from HercepTest \u2122 staining is provided in Table 1 for the entire population and for the specimens sampled consecutively .", "label": "", "metadata": {}, "score": "72.068596"}
{"text": "These data could be used as the basis for future clinical trials for targeting agents for advanced gastric cancer patients .Data provided are for informational purposes only .", "label": "", "metadata": {}, "score": "72.07704"}
{"text": "Fluorescence in situ hybridization ( FISH ) as primary methodology for the assessment of HER2 Status in adenocarcinoma of the breast : a single institution experience .", "label": "", "metadata": {}, "score": "72.08891"}
{"text": "In addition , anti - tumor activity was observed at all dose levels , including partial responses ( PRs ) and time - to - progression greater than or equal to 5 months , even in patients who were heavily pre - treated ( including anti - HER2 agents ) .", "label": "", "metadata": {}, "score": "72.13539"}
{"text": "PubMed View Article .Yu GZ , Chen Y , Wang JJ : Overexpression of Grb2/HER2 signaling in Chinese gastric cancer : their relationship with clinicopathological parameters and prognostic significance .", "label": "", "metadata": {}, "score": "72.138336"}
{"text": "evaluated tissue microarrays of primary tumour and lymph node positive metastases , where the HER2 status was assessable in 125 patients .In this patient group , a discordance rate of 7.2 % ( 9 patients ) was found overall .", "label": "", "metadata": {}, "score": "72.22457"}
{"text": "There have been conflicting results in studies that have assessed HER2 status with a combination of immunohistochemistry and in situ hybridisation of the primary and metastatic lesion ( Table 5 ) .", "label": "", "metadata": {}, "score": "72.23912"}
{"text": "1371 - 1379 , 2006 .View at Publisher \u00b7 View at Google Scholar .I. Garc\u00eda , F. Vizoso , A. Mart\u00edn et al . , \" Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer , \" Annals of Surgical Oncology , vol .", "label": "", "metadata": {}, "score": "72.25209"}
{"text": "PubMed View Article .Br J Cancer 2003 , 88 ( 10 ) : 1587 - 1591 .PubMed View Article .Lambros MB , Natrajan R , Reis - Filho JS : Chromogenic and fluorescent in situ hybridization in breast cancer .", "label": "", "metadata": {}, "score": "72.28482"}
{"text": "The use of BDISH technology allows the simultaneous analyses of two DNA targets within the context of tissue morphological observation .Background The human epidermal growth factor receptor 2 ( HER2 ) oncogene , located on the long arm of chromosome 17 ( 17q12-q21 ) , is over - expressed or amplified in approxi- mately 20 % of breast carcinoma cases [ 1,2].", "label": "", "metadata": {}, "score": "72.3463"}
{"text": "X. D. Shao , K. C. Wu , X. Z. Guo , M. J. Xie , J. Zhang , and D. M. Fan , \" Expression and significance of HERG protein in gastric cancer , \" Cancer Biology and Therapy , vol .", "label": "", "metadata": {}, "score": "72.35332"}
{"text": "It bears molecular similarities to HER2 -amplified breast cancer , and is yet to be adequately assessed for potential responsiveness to anti - HER2 therapy .", "label": "", "metadata": {}, "score": "72.376114"}
{"text": "J Clin Oncol 2007 , 25:118 - 145 .Garrison LP Jr , Lubeck D , Lalla D , Paton V , Dueck A , Perez EA : Cost- effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-postive breast cancer .", "label": "", "metadata": {}, "score": "72.384415"}
{"text": "By applying considerations common to the science of measurement ( metrology ) , one can maximise the impact of gene expression studies , increasing the likelihood of their translation to clinical tools .", "label": "", "metadata": {}, "score": "72.40445"}
{"text": "11 , pp .2193 - 2201 , 1995 .View at Publisher \u00b7 View at Google Scholar . H. E. Gabbert , W. Mueller , A. Schneiders et al . , \" Prognostic value of E - cadherin expression in 413 gastric carcinomas , \" International Journal of Cancer , vol .", "label": "", "metadata": {}, "score": "72.78667"}
{"text": "In their study , the discordant cases ( 20 % ) were caused by the specimen having FISH HER2/CEN 17 ratios between 1.7 and 2.3 that are close to the ' equivocal ' defined by ASCO / CAP HER2 scoring method ( 1.8 - 2.2 ) .", "label": "", "metadata": {}, "score": "72.79342"}
{"text": "The BDISH assay was developed with the nick translated dinitrophenyl ( DNP)-labeled HER2 DNA probe and DNP - labeled CEN 17 oligoprobe on the Ventana BenchMark(R ) XT slide processing system .", "label": "", "metadata": {}, "score": "72.89255"}
{"text": "Page 11 .Nonetheless , since consecutive tissue sections were not used for the FISH and BDISH analyses , one can speculate that the tissue sections for the FISH and BDISH tissue sec- tions contained tumor cell populations with different HER2 status .", "label": "", "metadata": {}, "score": "72.91617"}
{"text": "Hanna WM , Kwok K : Chromogenic in - situ hybridization : a via- ble alternative to fluorescence in - situ hybridization in the HER2 testing algorithm .", "label": "", "metadata": {}, "score": "72.980484"}
{"text": "Concordance rates between a set of gold standard dual color HER2 FISH scores and HER2 and CEN 17 BDISH scores by 4 observers were calculated for assessing the per- formance of the BDISH assay .", "label": "", "metadata": {}, "score": "73.00516"}
{"text": "MLA .Lambein , Kathleen , Marleen Praet , Ramses Forsyth , et al .\" Relationship Between Pathological Features , HER2 Protein Expression and HER2 and CEP17 Copy Number in Breast Cancer : Biological and Methodological Considerations .", "label": "", "metadata": {}, "score": "73.03406"}
{"text": "97 - 106 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .W. Yuan , Z. Chean , S. Wu et al . , \" Expression of EphA2 and E - cadherin in gastric cancer : correlated with tumor progression and lymphogenous metastasis , \" Pathology and Oncology Research , vol .", "label": "", "metadata": {}, "score": "73.05216"}
{"text": "22 , pp .944 - 949 , 1998 .View at Google Scholar \u00b7 View at Scopus . H. F. Gou , et al . , \" Expressions of COX-2 and VEGF - C in gastric cancer : correlations with lymphoangiogenesis and prognostic implications , \" Journal of Experimental & Clinical Cancer Research , vol .", "label": "", "metadata": {}, "score": "73.058716"}
{"text": "It was possible to examine HER2 status by fluorescent in situ hybridisation on paraffin - embedded tissue or fine needle aspirates .All but 2 of the 60 tumours were concordant ; one case demonstrated HER2 negative primary from one of three multifocal lesions , whilst the axillary nodal metastasis was positive .", "label": "", "metadata": {}, "score": "73.08297"}
{"text": "An international HER2 proficiency testing study showed that there was 20 % ( 4 out of 20 samples ) discordance with HER2 FISH testing among 5 experienced laboratories [ 15].", "label": "", "metadata": {}, "score": "73.135895"}
{"text": "Several groups have assessed the impact of systemic treatment with or without HER2 targeted therapy on subsequent tumour HER2 status .Results on 142 HER2-positive patients ( defined as IHC 3 + or amplification on ISH ) treated with neoadjuvant anthracyclines , taxanes and trastuzumab over the period 2004 - 2007 were reported from the MD Anderson Cancer Centre .", "label": "", "metadata": {}, "score": "73.14114"}
{"text": "Both are single arm phase II trials used in combination with gemcitabine [ 15 ] and capecitabine [ 16 ] .Although the latter performed HER2 FISH for 2 + expressing cases , the former did not , and neither verified the 3 + IHC cases by FISH .", "label": "", "metadata": {}, "score": "73.2059"}
{"text": "VEGF secretion promotes endothelial cell proliferation and therefore the establishment of a new vascular network .The evaluation of MVD reflects this latter process since it is evaluated by IHC with anti - CD34 or anti - CD31 antibodies which specifically indicate new formed vessels .", "label": "", "metadata": {}, "score": "73.24811"}
{"text": "If FISH is used as first screening step , only few IHC3 + cases may be missed but it might be found a high percentage of nonresponders according to ToGA results [ 24 , 68 ] .", "label": "", "metadata": {}, "score": "73.35797"}
{"text": "Results .The study population comprised of 116 patients with adequate tissue in both primary and metastasis .The concordance between HER2 status of the paired samples by local immunohistochemistry testing and central in - situ hybridization were 78 % and 99 % , respectively .", "label": "", "metadata": {}, "score": "73.52843"}
{"text": "While the concept of multi - color brightfield ISH applica- tions was published in 1990 's [ 40,41 ] , it was a recent achievement to visualize HER2 and CEN 17 targets within the same nuclei of tissue sections with a manual dual brightfield ISH application [ 42].", "label": "", "metadata": {}, "score": "73.540764"}
{"text": "However , few studies have been conducted to examine the frequency of HER2-positive tumors determined by the new criteria in resectable gastric cancer [ 20 , 21 ] , especially in a large Chinese cohort .", "label": "", "metadata": {}, "score": "73.59608"}
{"text": "The Kappa value was found at 0.90 [ 13 ] .McNemar 's test for a systematic bias between HER2 CISH and PathVysion FISH revealed a non - significant two - tailed p value of 1.00 indicating the absence of bias .", "label": "", "metadata": {}, "score": "73.61565"}
{"text": "Print .Abstract .Background .Chromogenic in situ hybridization ( CISH ) is fast becoming a well established technique for easy and sensitive determination of HER2 gene status in breast cancer .", "label": "", "metadata": {}, "score": "73.6559"}
{"text": "Owens MA , Horten BC , Da Silva MM : HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tis- sues .", "label": "", "metadata": {}, "score": "73.73031"}
{"text": "View Article .Zhonghua Bing Li Xue Za Zhi 2011 , 40 ( 5 ) : 296 - 299 .PubMed .Yan SY , Hu Y , Fan JG , Tao GQ , Lu YM , Cai X , Yu BH , Du YQ : Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma .", "label": "", "metadata": {}, "score": "73.79477"}
{"text": "PubMed View Article .Wang YK , Gao CF , Yun T , Chen Z , Zhang XW , Lv XX , Meng NL , Zhao WZ : Assessment of ERBB2 and EGFR gene amplification and protein expression in gastric carcinoma by immunohistochemistry and fluorescence in situ hybridization .", "label": "", "metadata": {}, "score": "73.93329"}
{"text": "Two patients with HER2 amplified primary breast cancers had apparent negative HER2 ISH status in metastatic deposits ( brain and pleural fluid respectively ) at initial blinded assessment .", "label": "", "metadata": {}, "score": "73.98091"}
{"text": "Virchows Arch 2007 , 451:19 - 25 .Grushko TA , Blackwood MA , Schumm PL , Hagos FG , Adeyanju MO , Feldman MD , Sanders MO , Weber BL , Olopade OI : Molecular- cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers .", "label": "", "metadata": {}, "score": "74.074356"}
{"text": "PubMed View Article .Chua TC , Merrett ND : Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes - A systematic review .", "label": "", "metadata": {}, "score": "74.13016"}
{"text": "4 , pp .246 - 251 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .W. Weichert , A. R\u00f6ske , V. Gekeler et al . , \" Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer : a retrospective analysis , \" The Lancet Oncology , vol .", "label": "", "metadata": {}, "score": "74.19745"}
{"text": "VEGF expression is mirrored by microvessel density ( MVD ) , and they are both hallmarks of enhanced angiogenesis within the tumor mass and are therefore useful tools for GC management [ 78 ] .", "label": "", "metadata": {}, "score": "74.19746"}
{"text": "For image comparison of BDISH and FISH for HER2 gene and CEN 17 , FISH images with MCF7 tumor and BT-474 tumor are presented in Figure 2 G and Figure 2H , respectively .", "label": "", "metadata": {}, "score": "74.27913"}
{"text": "All statistical analyses were performed using SPSS V.15.0 for Windows ( IBM SPSS Inc ) .Results .Patients ' characteristics .Complete clinicopathological information was obtained from medical records in 148 out of the 166 patients reviewed .", "label": "", "metadata": {}, "score": "74.43517"}
{"text": "Methods .Specimens .The study included 365 FFPE invasive breast cancer tissue specimens with known fixation history ( 10 % neutral buffered formalin , 18 - 24 h ) .", "label": "", "metadata": {}, "score": "74.495514"}
{"text": "One successful way to preserve the fast red staining was the use of a toluene - based Cytoseal 60 mounting medium placed onto completely dried tissue sections prior to cov- erslipping with glass coverslips .", "label": "", "metadata": {}, "score": "74.52704"}
{"text": "In the same issue of the journal , Amir et al . reported their prospective study of patients presenting with imaging suggestive of metastatic disease or who were experiencing progression while receiving palliative systemic treatment [ 11 ] .", "label": "", "metadata": {}, "score": "74.528595"}
{"text": "FISH PathVysion HER-2 DNA Probe Kit was used for the FISH test for HER2 and CEN 17 targets of xenograft tumor con- trols as previously described [ 30].", "label": "", "metadata": {}, "score": "74.53821"}
{"text": "The majority of the patients had been treated with adjuvant chemotherapy and trastuzumab .They reported significantly higher rates of HER2 discordance in those patients who had received adjuvant chemotherapy compared to those who had not .", "label": "", "metadata": {}, "score": "74.55501"}
{"text": "In addition to HER1 and HER2 , there is growing interest in HER3 as a potential therapeutic target [ 73 ] .Recently , HER3 and its physiologic ligand heregulin ( HRG ) have been implicated in the development of resistance to antiestrogen therapies in breast carcinoma [ 74 ] .", "label": "", "metadata": {}, "score": "74.558975"}
{"text": "13073_2013_477_MOESM1_ESM . xlsx Additional file 1 : Table S1 : Literature reports of Her2 positive rate in pancreatic ductal adenocarcinoma by immunohistochemistry and in situ hybridization techniques .", "label": "", "metadata": {}, "score": "74.633385"}
{"text": "HER2 status was assessed on paraffin sections by either single probe silver in situ hybridization ( SISH :Ventana Inform HER2 assay ) on Ventana XT automated stainer , or fluorescence in situ hybridization ( FISH : Vysis / Abbott PathVysion HER2/cep17 dual colour assay ) .", "label": "", "metadata": {}, "score": "74.633896"}
{"text": "The results of the ongoing multicenter studies evaluating MET - targeting agents are eagerly awaited as they may improve our understanding of the precise role of these agents in the treatment armamentarium of advanced GC .", "label": "", "metadata": {}, "score": "74.72406"}
{"text": "BISH assays .Abstract .Background .With varied immunohistochemistry scoring criteria and patient cohorts , HER2-positivity rates in gastric cancer ( GC ) and gastroesophageal junction ( GEJ ) adenocarcinoma have been reported with a wide range .", "label": "", "metadata": {}, "score": "74.817215"}
{"text": "12 , pp .1183 - 1188 , 2009 .View at Google Scholar \u00b7 View at Scopus .K. Maeda , S.-M. Kang , N. Onoda et al . , \" Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma , \" Cancer , vol .", "label": "", "metadata": {}, "score": "74.851524"}
{"text": "A total of 1463 patients , including 929 primary GCs and 534 primary GEJ adenocarcinomas , was retrospectively analyzed for HER2 overexpression by immunohistochemistry ( IHC ) .", "label": "", "metadata": {}, "score": "74.88317"}
{"text": "Another goal for margetuximab is to determine if the Fc modifications will improve clinical outcomes in patients with tumors that are currently treated with other HER2 therapies , which would be consistent with results seen in laboratory models .", "label": "", "metadata": {}, "score": "74.9129"}
{"text": "The molecular heterogeneity of PDAC implies that even an incidence of 2 % represents an attractive target for anti- HER2 therapies , as options for PDAC are limited .", "label": "", "metadata": {}, "score": "74.96261"}
{"text": "Mod Pathol 2004 , 17:277 - 287 .Park K , Kim J , Lim S , Han S , Lee JY : Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray .", "label": "", "metadata": {}, "score": "75.03263"}
{"text": "Biankin AV , Waddell N , Kassahn KS , et al .: Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes .Nature 2012 , 491 : 399 - 405 .", "label": "", "metadata": {}, "score": "75.03529"}
{"text": "133 - 138 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .X. Wang , W. Cao , M. Mo , W. Wang , H. Wu , and J. Wang , \" VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer , \" Journal of Surgical Oncology , vol .", "label": "", "metadata": {}, "score": "75.07721"}
{"text": "PubMed View Article .Swanton C , Futreal A , Eisen T : Her2-targeted therapies in non - small cell lung cancer .Clin Cancer Res 2006 , 12 : 4377s-4383s .", "label": "", "metadata": {}, "score": "75.121994"}
{"text": "Three of the six discordant cases for the comparison between HER2 CISH and HER2 FISH ( Table 3 ) were HercepTest \u2122 IHC 2 + equivocal cases , and the remaining three were 0 , 1 + and 3 + , respectively .", "label": "", "metadata": {}, "score": "75.21767"}
{"text": "30 , pp .3968 - 3976 , 2011 .View at Publisher \u00b7 View at Google Scholar .M.-S. Soon , L.-S. Hsu , C.-J. Chen et al . , \" Expression of Kruppel - like factor 5 in gastric cancer and its clinical correlation in Taiwan , \" Virchows Archiv , vol .", "label": "", "metadata": {}, "score": "75.242065"}
{"text": "Arch Pathol Lab Med 2006 , 130:325 - 331 .Br J Cancer 2003 , 88:1587 - 1591 .Zhao J , Wu R , Au A , Marquez A , Yu Y , Shi Z : Determination of HER2 gene amplification by chromogenic in situ hybridiza- tion ( CISH ) in archival breast carcinoma .", "label": "", "metadata": {}, "score": "75.24318"}
{"text": "Anyway , the possibility of validating potential tumor markers using IHC has clear advantages as it is easy and cost effective and virtually every pathology laboratory could perform it .", "label": "", "metadata": {}, "score": "75.29669"}
{"text": "Despite the current findings , the decision to obtain metastatic tissue for evaluation is influenced by other factors .These include disease - free interval , which may raise the possibility of a new malignancy and the accuracy of initial HER2 assessment of the primary tumour .", "label": "", "metadata": {}, "score": "75.30824"}
{"text": "Normal HER2 gene signal is seen as black dots in the nuclei of MCF7 xenograft tumor ( A ) while amplified HER2 gene signal is seen as clusters of black dots in the nuclei of BT-474 tumor ( B ) .", "label": "", "metadata": {}, "score": "75.56204"}
{"text": "Denaturation for 5 min at 82 \u00b0 C and over - night hybridization at 45 \u00b0 C were performed simultaneously for the HER2 /Texas Red labeled DNA probe and the CEN-17/FITC labeled PNA probe using a Hybridizer ( Dako Denmark A / S ) .", "label": "", "metadata": {}, "score": "75.601295"}
{"text": "Receptor dimerization can also occur through the process of receptor pairing , other than ligand binding [ 16 ] .Indeed , HER receptors can either homo- or hetero - dimerize with other HER family members , allowing multiple receptor combinations [ 16 , 17 ] .", "label": "", "metadata": {}, "score": "75.66832"}
{"text": "Due to the retrospective nature of this study , none of the obtained results was used to modify the treatment of patients .Immunohistochemistry .The HER2 protein status was determined by IHC using the Pathway anti - HER2/ neu ( 4B5 ) antibody in the fully automated platform BenchMark ULTRA \u00ae ( Ventana Medical Systems , Inc , Tucson , Arizona , USA ) .", "label": "", "metadata": {}, "score": "75.73062"}
{"text": "139 - 148 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. Xu , X. Li , E. S. Chu et al . , et al . , \" Epigenetic inactivation of BCL6B , a novel functional tumour suppressor for gastric cancer , is associated with poor survival , \" GUT , vol .", "label": "", "metadata": {}, "score": "75.739975"}
{"text": "One pathologist reviewed test results obtained with PathVysion HER-2 DNA Probe Kit and HER2 CISH pharmDx \u2122 Kit with several months in between and another pathologist reviewed test results obtained with HER2 FISH pharmDx \u2122 Kit .", "label": "", "metadata": {}, "score": "75.8197"}
{"text": "415 - 419 , 2012 .View at Publisher \u00b7 View at Google Scholar .S. Osinsky , L. Bubnovskaya , I. Ganusevich et al . , \" Hypoxia , tumour - associated macrophages , microvessel density , VEGF and matrix metalloproteinases in human gastric cancer : interaction and impact on survival , \" Clinical and Translational Oncology , vol .", "label": "", "metadata": {}, "score": "75.85265"}
{"text": "She continued treatment with trastuzumab - based therapy with the addition of endocrine treatment and continues to have responsive disease to the present time ( 64 months ) .", "label": "", "metadata": {}, "score": "75.92558"}
{"text": "Further we have demonstrated that in situ hybridisation is more accurate than immunohistochemistry and less susceptible to sample processing variables .The use of a combination of immunohistochemistry and in situ hybridisation or other non - standard methods of evaluation ( such as automated subcellular localization and quantification of protein expression multiplex ligation - dependent probe amplification ) may also influence the interpretation of results .", "label": "", "metadata": {}, "score": "75.99929"}
{"text": "Previous studies including all pathological stages have also reported no correlation between pathological stage and overexpression [ 20 , 21 , 24 ] .However , other studies demonstrated both an association and no association between HER2 overexpression and tumor differentiation [ 25 , 32 , 34 , 35 ] .", "label": "", "metadata": {}, "score": "76.02291"}
{"text": "EW , MK , MD , RRT , and TMG cri- tiqued the assay performance with their molecular histol- ogy expertise during the assay development .", "label": "", "metadata": {}, "score": "76.06017"}
{"text": "Page 7 .When CEN 17 probe was omitted from the complete BDISH assay , there was no fast red staining on xenograft tumor sections ( data not shown ) .", "label": "", "metadata": {}, "score": "76.24963"}
{"text": "The study was performed after approval by the Local Research Ethics Committee and in accordance with the Declaration of Helsinki , the Good Clinical Practices , and local ethical and legal requirements .", "label": "", "metadata": {}, "score": "76.294495"}
{"text": "774 - 779 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. Kondo , T. Kaneko , M. Baba , and H. Konno , \" VEGF - C and VEGF - A synergistically enhance lymph node metastasis of gastric cancer , \" Biological and Pharmaceutical Bulletin , vol .", "label": "", "metadata": {}, "score": "76.34053"}
{"text": "668 - 673 , 2011 .View at Google Scholar . F. Graziano , A. Mandolesi , A. Ruzzo et al . , \" Predictive and prognostic role of E - cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy , \" Tumor Biology , vol .", "label": "", "metadata": {}, "score": "76.627686"}
{"text": "Testing anti- HER2 therapies may not be feasible in organ groups because of this low prevalence and the likely heterogeneous response rates .Abbreviations .ISH : .", "label": "", "metadata": {}, "score": "76.67854"}
{"text": "\"Journal of Clinical Pathology 64 ( 3 ) : 200 - 207 .APA .Lambein , Kathleen , Praet , M. , Forsyth , R. , Van den Broecke , R. , Braems , G. , MATTHYS , B. , Cocquyt , V. , et al .", "label": "", "metadata": {}, "score": "76.75192"}
{"text": "The 8 discordant cases were re - evaluated by FISH and 5 of the cases were found to be concordant .Reasons for the discordant initial assessment included interpretational error with the HER2/reference ratio being close to 2.0 in three patients , and re - evaluation identified the presence of scanty amplified malignant cells which had been initially overlooked in two patients [ 13 ] .", "label": "", "metadata": {}, "score": "76.85862"}
{"text": "Current therapeutic development is focused on targeting molecular mechanisms , and this has resulted in significant improvements in outcome for several cancer types ( for example , crizotinib for EML4-ALK fusion - positive non - small cell lung cancer ( NSCLC ) ) .", "label": "", "metadata": {}, "score": "77.1035"}
{"text": "[ 10 ] .Non - synonymous mutations were assessed for functional effects by two algorithms , Polyphen2 and SIFT ; scores close to 1.0 and 0.0 , respectively , are predicted to be probably damaging .", "label": "", "metadata": {}, "score": "77.10367"}
{"text": "Table S5 : Genes affected by structural variation , as determined by whole genome sequencing of tissue from a patient with HER2 amplification .Table S6 : Structural and copy number aberrations in a patient identified with HER2 amplification .", "label": "", "metadata": {}, "score": "77.109566"}
{"text": "13 Only a low percentage of discordant cases were observed between FISH and dc - SISH or between IHC and FISH , which were resolved by quantitative RT - PCR .", "label": "", "metadata": {}, "score": "77.13144"}
{"text": "Survival analyses ( OS and PFS ) according to HER2 + status were performed using the Kaplan - Meier method and differences between the patient groups were tested by the log - rank test .", "label": "", "metadata": {}, "score": "77.23011"}
{"text": "One case was found to have intra - tumoral heterogeneity by IHC and ISH , with distinct HER2 -positive and HER2 -negative areas .Clinicopathological features of HER2 -amplified pancreatic ductal adenocarcinoma ( PDAC ) .", "label": "", "metadata": {}, "score": "77.37785"}
{"text": "43 , no . 3 , pp .413 - 422 , 2012 .View at Publisher \u00b7 View at Google Scholar .C. K. Osborne , P. Neven , L. Y. Dirix et al . , \" Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor - positive metastatic breast cancer : a randomized phase II study , \" Clinical Cancer Research , vol .", "label": "", "metadata": {}, "score": "77.380936"}
{"text": "Overall survival according to HER2 overexpression by immunohistochemistry ( IHC ) ( A ) , HER2 gene amplification by fluorescence in situ hybridisation ( FISH ) ( B ) or dual colour silver enhanced in situ hybridisation ( SISH ) ( C ) techniques .", "label": "", "metadata": {}, "score": "77.435036"}
{"text": "273 - 278 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .Z.-Q. Zhao , S. Yang , and H.-S. Lu , \" Expression of midkine and vascular endothelial growth factor in gastric cancer and the association of high levels with poor prognosis and survival , \" Molecular Medicine Reports , vol .", "label": "", "metadata": {}, "score": "77.48942"}
{"text": "The prognostic value of HER2 in gastric cancer ( GC ) is controversial and historically its overexpression and/or amplification have been considered a poor prognosis factor .", "label": "", "metadata": {}, "score": "77.5022"}
{"text": "4 , pp .633 - 637 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Iordache , A. Saftoiu , C. V. Georgescu et al . , \" Vascular endothelial growth factor expression and microvessel density - two useful tools for the assessment of prognosis and survival in gastric cancer patients , \" Journal of Gastrointestinal and Liver Diseases , vol .", "label": "", "metadata": {}, "score": "77.509415"}
{"text": "MacroGenics has engineered margetuximab for increased binding to the low affinity allele of CD16A , thus offering potentially increased effectiveness in the approximately 85 % of patients who carry this Fc gamma R allele .", "label": "", "metadata": {}, "score": "77.5877"}
{"text": "View at Google Scholar \u00b7 View at Scopus .J. C. Machado , F. Carneiro , S. Beck et al . , \" E - cadherin expression is correlated with the isolated cell / diffuse histotype and with features of biological aggressiveness of gastric carcinoma , \" International Journal of Surgical Pathology , vol .", "label": "", "metadata": {}, "score": "77.6935"}
{"text": "Although preclinical studies support potential efficacy of trastuzumab in PDAC [ 13 , 14 ] , clinical trials have been hampered by non - standardized assays and a consequent lack of focus on appropriate subgroups [ 15 , 16 ] .", "label": "", "metadata": {}, "score": "77.70535"}
{"text": "Todorovi\u0107 - Rakovi\u0107 N , Jovanovi\u0107 D , Neskovi\u0107 - Konstantinovi\u0107 Z , Nikoli\u0107 - Vukosavljevi\u0107 D : Prognostic value of HER2 gene ampli- fication detected by chromogenic in situ hybridization ( CISH ) in metastatic breast cancer .", "label": "", "metadata": {}, "score": "77.730606"}
{"text": "View Article .Dwyer AJ : Matchmaking and McNemar in the comparison of diagnostic modalities .Radiology 1991 , 178 ( 2 ) : 328 - 330 .", "label": "", "metadata": {}, "score": "77.83731"}
{"text": "All breast cancer cases had been previously tested for HER2 status by FISH using the PathVysion \u00ae HER-2 DNA Probe Kit ( Abbott Molecular , Des Plaines , Illinois ) at the Cleveland Clinic Foundation .", "label": "", "metadata": {}, "score": "78.049034"}
{"text": "PubMed View Article .Weissinger F , Reymond M , Dumke K , Kruger M : Successful treatment of a patient with HER2-positive metastatic gastric cancer with third - line combination therapy with irinotecan , 5-fluorouracil , leucovorin and trastuzumab ( FOLFIRI - T ) .", "label": "", "metadata": {}, "score": "78.11046"}
{"text": ": Core signaling pathways in human pancreatic cancers revealed by global genomic analyses .Science 2008 , 321 : 1801 - 1806 .PubMed View Article .", "label": "", "metadata": {}, "score": "78.15066"}
{"text": "Dual colour silver enhanced in situ hybridisation .Automated dc - SISH was performed on Ventana Benchmark XT ( Ventana Medical Systems ) .INFORM HER2 DNA Probe and INFORM Chromosome 17 Probe were visualised on the same slide following manufacturer 's protocols with a few variations .", "label": "", "metadata": {}, "score": "78.28015"}
{"text": "a The criteria used for scoring HER2 by immunohistochemistry and in situ hybridization in PDAC were as follows .Her2 IHC score criteria ( modified from Hofmann et al [ 21 ] ): 0 , no staining of any pattern or intensity ; 1 + .", "label": "", "metadata": {}, "score": "78.32321"}
{"text": "HER2 amplification in pancreatic ductal adenocarcinoma .In order to define the clinical and histopathological characteristics , diagnostic criteria , and prevalence of HER2 amplification in PDAC , we assessed a cohort of 469 patients with resected PDAC using IHC and in situ hybridization ( ISH ) .", "label": "", "metadata": {}, "score": "78.43869"}
{"text": "Several large studies have reported an extremely low incidence of MET gene amplification ( GA ) in patients with radically resected gastric cancer .MET GA and strong protein expression(IHC31 ) were observed in 8.3 % ( 19 of 230 samples ) and 9.6 % ( 22 of 229 samples ) of samples , respectively .", "label": "", "metadata": {}, "score": "78.4706"}
{"text": "Millar JA , Millward MJ : Cost effectiveness of trastuzumab in the early breast cancer : a lifetime model .Pharmocoeconomics 2007 , 25:429 - 442 .", "label": "", "metadata": {}, "score": "78.478424"}
{"text": "Imaging results of patient 9 ( Table 2 ) showing ( D ) cerebral and ( E ) lung metastases , and ( F ) absence of liver metastases .", "label": "", "metadata": {}, "score": "78.540085"}
{"text": "Dr. Burris commented , \" We were pleased to find that margetuximab was well tolerated by patients and showed promising activity in patients who have limited treatment options , such as those with breast cancer or gastroesophageal cancer and who previously have failed other HER2 therapies .", "label": "", "metadata": {}, "score": "78.54996"}
{"text": "Recently , Niikura et al .identified forty - three ( 24 % ) of the 182 patients with HER2 positive primary tumors as having metastatic tumors which were HER2 negative [ 10 ] .", "label": "", "metadata": {}, "score": "78.572784"}
{"text": "HER family members are implicated in the development of different kinds of tumors and are now recognized targets for biological therapy in breast , colorectal , lung , head and neck , gastric and gastro - oesophageal junction cancer ( reviewed in [ 15 ] ) .", "label": "", "metadata": {}, "score": "78.575195"}
{"text": "PubMed View Article .Pre - publication history .Copyright .\u00a9 Chan et al . ; licensee BioMed Central Ltd. 2012 .This article is published under license to BioMed Central Ltd. Development of automated brightfield double In Situ hybridization ( BDISH ) application for HER2 gene and chromosome 17 centromere ( CEN 17 ) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization ( FISH ) .", "label": "", "metadata": {}, "score": "78.62891"}
{"text": "Fur- thermore , this application has the potential to be used for other gene targets , any combination of a gene and its chro- mosome centromere , and tissue section - based gene assessment tests including gene translocation studies .", "label": "", "metadata": {}, "score": "78.64568"}
{"text": "The diffuse type GC is characterized by reduced or abnormal E - cadherin expression [ 10 , 11 ] .According to this model , the intraepithelial presence of signet - ring cells does not represent a secondary colonization .", "label": "", "metadata": {}, "score": "78.70623"}
{"text": "c Only case 9 received palliative chemotherapy ( gemcitabine + erlotinib ) and also received adjuvant gemcitabine .Table 3 .Clinicopathological characteristics of HER2 amplified and HER2 non - amplified cases .", "label": "", "metadata": {}, "score": "78.820435"}
{"text": "Despite not being a randomised study ( which can be considered a potential weakness of our trial ) patients were not selected but were included consecutively as soon as they were referred for assessment ; this fact diminishes the possible selection bias .", "label": "", "metadata": {}, "score": "78.89052"}
{"text": "135 - 144 , 1998 .View at Google Scholar \u00b7 View at Scopus .J. Teruya - Feldstein , \" The immunohistochemistry laboratory looking at molecules and preparing for tomorrow , \" Archives of Pathology and Laboratory Medicine , vol .", "label": "", "metadata": {}, "score": "78.891266"}
{"text": "Theodosiou Z , Kasampalidis IN , Karayannopoulou G , Kostopoulos I , Bobos M , Bevilacqua G , Aretini P , Starita A , Lyroudia K , Pitas I : Eval- uation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases .", "label": "", "metadata": {}, "score": "78.90735"}
{"text": "Double staining of HER2 gene and CEN 17 is obtained with silver grains and red dots ( E , F ) .Individual HER2 gene and CEN 17 signals can be still recognized when both targets are co - localized ( arrow heads , E ) .", "label": "", "metadata": {}, "score": "78.931725"}
{"text": "473 - 478 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. T. Shun , M. S. Wu , J. T. Lin et al . , \" An immunohistochemical study of E - cadherin expression with correlations to clinicopathologioal features in gastric cancer , \" Hepato - Gastroenterology , vol .", "label": "", "metadata": {}, "score": "79.12215"}
{"text": "In non - amplified tumours , the mean CEP17 and HER2 copy number correlated , possibly because of cell cycling .Amplified tumours were histopathologically more aggressive than non - amplified tumours , and features of aggressiveness increased with the mean HER2 copy number .", "label": "", "metadata": {}, "score": "79.19458"}
{"text": "Genomic characteristics of HER2 -amplified pancreatic ductal adenocarcinoma .Whole genome and exome sequencing identified several classes of mutation including single nucleotide variants , small insertions and deletions ( indels ) , and chromosomal rearrangements ( see Additional file 5 ) .", "label": "", "metadata": {}, "score": "79.220314"}
{"text": "Furthermore , the benefits of trastuzumab in metastatic breast cancer are primarily in patients who are homozygous for the high affinity allele of the Fc gamma receptor , CD16A ( Fc gamma RIIIA ) .", "label": "", "metadata": {}, "score": "79.280785"}
{"text": "13073_2013_477_MOESM5_ESM . xlsx Additional file 5 : Table S3 : Single nucleotide variations ( SNVs ) and small insertions or deletions ( indels ) within a patient with HER2 amplification , identified by whole exome sequencing , in MAF format .", "label": "", "metadata": {}, "score": "79.33198"}
{"text": "Scoring of BDISH assays was also ana- lyzed for the sensitivity and specificity against FISH scores with the historical scoring method and the ASCO / CAP scoring method without the equivocal cases .", "label": "", "metadata": {}, "score": "79.37952"}
{"text": "Histopathology 2008 , 52 : 797 - 805 .PubMed View Article .Kennecke H , Yerushalmi R , Woods R , Cheang MC , Voduc D , Speers CH , Nielsen TO , Gelmon K : Metastatic behavior of breast cancer subtypes .", "label": "", "metadata": {}, "score": "79.37953"}
{"text": "The American Society of Clini- cal Oncology and the College of American Pathologists has published a guideline recommendation for testing HER2 status in breast cancer [ 3 ] and the Canadian National Consensus has updated the Canadian HER2/neu testing guideline [ 35].", "label": "", "metadata": {}, "score": "79.439514"}
{"text": "681 - 687 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. Mayer , J. P. Johnson , F. Leitl et al . , \" E - cadherin expression in primary and metastatic gastric cancer : down - regulation correlates with cellular dedifferentiation and glandular disintegration , \" Cancer Research , vol .", "label": "", "metadata": {}, "score": "79.45053"}
{"text": "Consequently , without adequate consideration of experimental standardisation , such findings may be sufficient for a given publication but can not be translated to wider clinical application .", "label": "", "metadata": {}, "score": "79.45434"}
{"text": "PubMed View Article .Zhan GH : Multicenter study on HER-2/neu gene amplification and protein expression in patients with gastric cancer .Chin J Dig 2006 , 26 ( 10 ) : 657 - 660 .", "label": "", "metadata": {}, "score": "79.48273"}
{"text": "G.-C.Li , Z. Zhang , X.-J. Ma , W.-L. Gu , Y.-N. Wang , and J. Li , \" Are biomarkers correlated with recurrence patterns in patients with resectable gastric adenocarcinoma , \" Molecular Biology Reports , vol .", "label": "", "metadata": {}, "score": "79.62208"}
{"text": "FISH : .Fluorescent in situ hybridization .SISH : .Silver in situ hybridization .cep17 : .Chromosome 17 centromere .DTC : .", "label": "", "metadata": {}, "score": "79.73308"}
{"text": "Giotta et al . demonstrated in a small study of 20 patients that it was feasible to perform in situ hybridisation on cytological specimens obtained from 21 - 23 gauge needle biopsies [ 8 ] .", "label": "", "metadata": {}, "score": "79.76432"}
{"text": "Noteworthy , in the three HER2 determination techniques used the mean OS rates in HER2 + patients in our study almost doubled those achieved in HER2 patients .", "label": "", "metadata": {}, "score": "79.827896"}
{"text": "4 , pp .325 - 330 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. Zhou , \" Clinicapathological significance of E - cadherin , VEGF , and MMPs in gastric cancer , \" Tumor Biology , vol .", "label": "", "metadata": {}, "score": "79.976425"}
{"text": "JM , UH , SM and AS are employees at Dako Denmark A / S. Authors ' contributions .The clinical trial was planned by UH , AS and JM .", "label": "", "metadata": {}, "score": "80.01466"}
{"text": "135 - 139 , 2010 .View at Google Scholar \u00b7 View at Scopus .P. Aurello , R. Bellagamba , S. R. Del Monte et al . , \" Apoptosis and microvessel density in gastric cancer : correlation with tumor stage and prognosis , \" American Surgeon , vol .", "label": "", "metadata": {}, "score": "80.083626"}
{"text": "184 - 189 , 1996 .View at Publisher \u00b7 View at Google Scholar . H. C. Chen , R. Y. Chu , P. N. Hsu et al . , \" Loss of E - cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas , \" Cancer Letters , vol .", "label": "", "metadata": {}, "score": "80.22442"}
{"text": "In this study , 143 of 1463 ( 9.8 % ) of GC and GEJ adenocarcinoma cases were HER2-positive ( 3 + ) by IHC in one of the largest Chinese studies to date .", "label": "", "metadata": {}, "score": "80.275375"}
{"text": "Peir\u00f3 G , Mayr D , Hillemanns P , L\u00f6hrs U , Diebold J : Analysis of HER-2/neu amplification in endometrial carcinoma by chro- mogenic in situ hybridization .", "label": "", "metadata": {}, "score": "80.38719"}
{"text": "Eight patients ( 32 % ) had residual disease which was HER2 negative and at median follow - up of 37 months , this group of patients had significantly inferior relapse - free survival compared to those patients whose residual disease remained HER2 positive [ 17 ] .", "label": "", "metadata": {}, "score": "80.413605"}
{"text": "Furthermore , tissue slides for the dual color FISH test are still processed manually in most laboratories , which practice can introduce human errors during the lengthy assay .", "label": "", "metadata": {}, "score": "80.41532"}
{"text": "Also , chro- mosome 17 polysomy is a key prognosis indicator for breast cancer patients .Patients with chromosome 17 polysomy and no HER2 gene amplification have better prognosis compared to patients with HER2 gene amplifi- cation [ 11].", "label": "", "metadata": {}, "score": "80.41733"}
{"text": "The dc - SISH amplification ratio was between 2 and 3 and all of them were IHC 0/1 + .All these cases were polysomic and were confirmed as negative for amplification by RT - PCR .", "label": "", "metadata": {}, "score": "80.42473"}
{"text": "2784 - 2789 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. N. Zhou , C. P. Xu , B. Han et al . , \" Expression of E - cadherin and \u03b2 -catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival , \" World Journal of Gastroenterology , vol . 8 , no .", "label": "", "metadata": {}, "score": "80.434586"}
{"text": "164 - 169 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Kawakami , R. S. Machado , S. K. Ogata , and M. Langner , \" Decrease in prevalence of Helicobacter pylori infection during a 10-year period in Brazilian children , \" Arquivos de Gastroenterologia , vol .", "label": "", "metadata": {}, "score": "80.4384"}
{"text": "In a recent meta - analysis the median percentage of specimens in the IHC 2 + and IHC 3 + category were found at 12.0 % and 16.2 % [ 12 ] which indicate a low percentage of IHC 3 + specimens in this investigation .", "label": "", "metadata": {}, "score": "80.455315"}
{"text": "However , the standard coverslipping method with aqueous mounting medium on wet tissue sections did not produce tissue sections with high resolution and therefore detailed tissue structure could not be observed ( data not shown ) .", "label": "", "metadata": {}, "score": "80.47236"}
{"text": "At a dose of 0.1 mg / kg qw , one patient experienced time to progression of 9.2 months .In addition , three patients experienced confirmed partial responses ( RECIST ) two with metastatic breast cancer ( lasting 3.3 and 5.3 months ) and one with cancer of the gastroesophageal junction ( lasting 3.3 months ) .", "label": "", "metadata": {}, "score": "80.53058"}
{"text": "Clinical data were collected from medical records by a single clinician blinded to HER2 status , using a datasheet specifically developed for this study .Clinicopathological data such as gender , age , histological type according to the Lauren 's classification 15 number and locations of metastases , previous surgery for GC and chemotherapy treatment received were reviewed .", "label": "", "metadata": {}, "score": "80.57187"}
{"text": "24 , pp .6735 - 6740 , 1992 .View at Google Scholar \u00b7 View at Scopus .F. Carneiro , D. G. Huntsman , T. C. Smyrk et al . , \" Model of the early development of diffuse gastric cancer in E - cadherin mutation carriers and its implications for patient screening , \" Journal of Pathology , vol .", "label": "", "metadata": {}, "score": "80.59116"}
{"text": "Fagnani F , Colin X , Arveux P , Coudert B , Misset JL : Cost / effective- ness analysis of adjuvant therapy with trastuzumab in patients with HER2 positive early breast cancer .", "label": "", "metadata": {}, "score": "80.64466"}
{"text": "( XLSX 96KB ) .13073_2013_477_MOESM10_ESM . xlsx Additional file 10 : Table S9 : Incidence of and deaths from HER2 -amplified cancers in the USA .", "label": "", "metadata": {}, "score": "80.66356"}
{"text": "13073_2013_477_MOESM7_ESM . xlsx Additional file 7 : Table S8 : MSigDB analysis of all genes affected by mutation , tructural variation ( SV ) and copy number variation ( CNV ) ( from Additional file 6 : Table S7 ) .", "label": "", "metadata": {}, "score": "80.73539"}
{"text": "Results BDISH assay optimization Images of HER2 single ISH , CEN 17 single ISH , and HER2 and CEN 17 BDISH results with formalin - fixed , paraffin- embedded xenograft tumor sections are presented in Fig- ure 2 .", "label": "", "metadata": {}, "score": "80.74394"}
{"text": "Additional IHC on the pleural fluid cell block confirmed the presence of reactive mesothelial cells only .These cases were thus retrospectively classified as \" ineligible \" due to the absence of assessable metastatic breast cancer , but have been included in Table 3 for completeness .", "label": "", "metadata": {}, "score": "80.921326"}
{"text": "Several publications have reported discordance in the HER2 status between primary breast cancer and metastatic disease .The alteration in the HER2 status from positive to negative has ranged from 2 % to 42 % .", "label": "", "metadata": {}, "score": "81.168365"}
{"text": "BMC cancer 2009 , 9 : 433 .PubMed View Article .Hudson TJ , Anderson W , Aretz A , et al .: International Network of Cancer Genome Projects .", "label": "", "metadata": {}, "score": "81.305466"}
{"text": "Of the ten patients with HER2 amplified tumours , nine died of PDAC , and one died of respiratory failure as a result of chronic obstructive pulmonary disease with no evidence of cancer recurrence .", "label": "", "metadata": {}, "score": "81.34463"}
{"text": "Excluding breast and stomach , for which HER2 diagnostic assays are common practice , we expect 740,000 new cases , 22,000 of which will be HER2 -amplified .", "label": "", "metadata": {}, "score": "81.34959"}
{"text": "Patient and tumour characteristics of the study population and those who had a recurrence biopsy but were ineligible are shown in Table 1 .Patients in the study group were more likely to have had a recent breast cancer diagnosis with less than a 2-year interval between the paired biopsies .", "label": "", "metadata": {}, "score": "81.38088"}
{"text": "The ToGA study developed a new set of IHC scoring criteria based on the study by Hofmann et al .[19 ] and found HER2-positive ( defined as IHC 3 + or IHC 2+/FISH+ ) tumors in 16 % of metastatic GC cases .", "label": "", "metadata": {}, "score": "81.41739"}
{"text": "There was no commu- nication among observers regarding their scoring experi- ence of the BDISH slides .Concordance data of FISH scores vs. consensus BDISH scores among 4 observers and FISH scores vs. individual BDISH scores by 4 observers were determined using SAS 9.1 ( SAS Institute Inc , Cary , North Carolina ) in calculating frequency tables and Kappa statistics .", "label": "", "metadata": {}, "score": "81.41824"}
{"text": "131 - 138 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .X. Liu , H. Cai , H. Huang , Z. Long , Y. Shi , and Y. Wang , \" The prognostic significance of apoptosis - related biological markers in chinese gastric cancer patients , \" PLoS ONE , vol .", "label": "", "metadata": {}, "score": "81.46263"}
{"text": "11 , pp .855 - 863 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Ananiev , et al . , \" Relation between transforming growth factor - b1 expression , its receptor and clinicopathological factors and survival in HER2-negative gastric cancers , \" Wiener Klinische Wochenschrift , vol .", "label": "", "metadata": {}, "score": "81.54023"}
{"text": "5 , pp .1010 - 1016 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Ohtsu , M. A. Shah , E. Van Cutsem et al . , \" Bevacizumab in combination with chemotherapy as first - line therapy in advanced gastric cancer : a randomized , double - blind , placebo - controlled phase III study , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "81.5966"}
{"text": "Advantages of SISH include the high sensitivity for detection of single gene copies , the high resolution for quantifying DNA targets , and the high contrast with tissue counterstaining for visual separation of the signal and tissue morphology [ 27].", "label": "", "metadata": {}, "score": "81.6478"}
{"text": "PubMed View Article .Brown LD , Cai T , DasGupta A : Interval Estimation for a Binomial Proportion .Stat Sci 2001 , 16 ( 2 ) : 101 - 133 .", "label": "", "metadata": {}, "score": "81.72203"}
{"text": "DAB , BCIP / NBT , and TMB detection systems did not provide sufficient contrast against HER2 ISH black sig- nal ( data not shown ) .", "label": "", "metadata": {}, "score": "81.84334"}
{"text": "Three of these specimens are overlapping and therefore , 348 specimens were eligible for comparison between HER2 CISH and HER2 FISH .The Kappa value was found at 0.92 [ 13 ] .", "label": "", "metadata": {}, "score": "81.91968"}
{"text": "This case was analyzed further using whole genome sequencing , copy number analysis , and mRNA expression profiling .HER2 -amplified pancreatic ductal adenocarcinoma .( A ) Single nucleotide polymorphism ( SNP ) array showing amplification on chromosome 17 containing the HER2 locus ( boxed ) .", "label": "", "metadata": {}, "score": "81.98596"}
{"text": "Histopathology 2010 , 56 : 472 - 480 .PubMed View Article .Pedersen M , Rasmussen BB : The correlation between dual - color chromogenic in situ hybridization and fluorescence in situ hybridization in assessing HER2 gene amplification in breast cancer .", "label": "", "metadata": {}, "score": "81.99356"}
{"text": "Good total agreement ( 89 % ) was observed with the anti - MET antibody clone SP44 using whole - tissue sections , but poor positive agreement ( 21 - 47 % ) was seen in tissue microarray cores .", "label": "", "metadata": {}, "score": "82.05344"}
{"text": "5 , pp .1147 - 1159 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Baselga , J. Albanell , A. Ruiz et al . , \" Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "82.266785"}
{"text": "Results .Patient characteristics .Forty - one patients were excluded from this study due to insufficient tissue being available for central analysis ; thus 116 patients constitute the study population .", "label": "", "metadata": {}, "score": "82.37163"}
{"text": "Despite FISH being considered the gold standard for HER2 gene amplification , a number of barriers such as the need of specialised equipment or the lack of morphological examination control prevent its wider use in the clinical setting .", "label": "", "metadata": {}, "score": "82.37538"}
{"text": "Diagn Pathol 2012 , 7 : 60 .PubMed View Article .Diagn Pathol 2008 , 3 : 41 .PubMed View Article .Slamon DJ , Leyland - Jones B , Shak S , Fuchs H , Paton V , Bajamonde A , Fleming T , Eiermann W , Wolter J , Pegram M : Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 .", "label": "", "metadata": {}, "score": "82.48688"}
{"text": "Hopman AHN , Claessen S , Speel EJM : Multi - colour brightfield in situ hybridization on tissue sections .Histochem Cell Biol 1997 , 108:291 - 298 .", "label": "", "metadata": {}, "score": "82.489296"}
{"text": "145 - 152 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. H. Jeong , J. H. Han , J. H. Kim et al . , \" Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil , leucovorin , and oxaliplatin palliative chemotherapy , \" Digestive Diseases and Sciences , vol .", "label": "", "metadata": {}, "score": "82.5495"}
{"text": "13073_2013_477_MOESM8_ESM . xlsx Additional file 8 : Figure S2 : Gene expression profiles from 90 pancreatic cancer primary tumors , classified into five intrinsic breast subtypes by the PAM50 classifier .", "label": "", "metadata": {}, "score": "82.60774"}
{"text": "HER2 signals were visualized as discrete black metallic silver dots while CEN 17 signals were detected as slightly larger red dots .Conclusion : Automated BDISH applications for HER2 and CEN 17 targets were successfully developed and it might be able to replace manual two - color HER2 FISH methods .", "label": "", "metadata": {}, "score": "82.68655"}
{"text": "6 , pp .655 - 666 , 2000 .View at Google Scholar \u00b7 View at Scopus . Y. Shino , A. Watanabe , Y. Yamada et al . , \" Clinicopathologic evaluation of immunohistochemical E - cadherin expression in human gastric carcinomas , \" Cancer , vol .", "label": "", "metadata": {}, "score": "82.70109"}
{"text": "AJ , APGI , LC , HW , JS , AG , DKC and AVB were involved in provision of study materials or patients : All authors were involved in manuscript writing and final approval of the manuscript .", "label": "", "metadata": {}, "score": "82.70485"}
{"text": "Competing interests .The remaining authors declare that they have no competing interests .Authors ' contributions .AC , NW , MJC , AJG , DKC , JW , MP , ALJ , AMN , CT , VC , LC , JH , JSS , ALM , SMG , and AVB were responsible for the concept and design of the study .", "label": "", "metadata": {}, "score": "82.82626"}
{"text": "The amplified specimen ( left panel ) have cluster amplification in which red signals are overlapping , but some single red signals are also visible in some tumor cells .", "label": "", "metadata": {}, "score": "82.88251"}
{"text": "Pertuzumab is a recombinant humanized monoclonal antibody directed against the dimerization domain II of HER2 that is required for ligand - dependent dimerization with HER3 [ 74 ] .", "label": "", "metadata": {}, "score": "82.89642"}
{"text": "HER2 gene amplification studied by either fluorescence in situ hybridisation or dual colour silver enhanced in situ hybridisation is significantly associated with favourable survival .HER2 gene amplification approaches might be an optimal testing strategy for the selection of patients who are candidates to be treated with anti - HER2 therapies .", "label": "", "metadata": {}, "score": "82.93944"}
{"text": "987 - 993 , 2002 .View at Google Scholar \u00b7 View at Scopus . Y. E. Joo , C. S. Park , H. S. Kim , S. K. Choi , J. S. Rew , and S. J. Kim , \" Prognostic significance of E - cadherin / catenin complex expression in gastric cancer , \" Journal of Korean Medical Science , vol .", "label": "", "metadata": {}, "score": "82.99325"}
{"text": "With the recent initiation of a Phase 2 clinical trial , we will explore whether margetuximab can improve clinical outcomes in a sub - population of breast cancer patients , particularly those with low HER2 expression .", "label": "", "metadata": {}, "score": "83.00073"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : AimsDevelopment of novel targeted therapies directed against hepatocyte growth factor ( HGF ) or its receptor ( MET ) necessitates the availability of quality diagnostics to facilitate their safe and effective use .", "label": "", "metadata": {}, "score": "83.04363"}
{"text": "Competing interests HN , BHW , ML , AEM , FG , MF , EW , TM are employed by Ventana Medical Systems , Inc. RRT and MD received grant support and honorarium for speaking from Ventana Med- ical Systems , Inc. Authors ' contributions LW , ML , JP , and RRT were responsible for identifying and prequalification of the clinical cases used in this study .", "label": "", "metadata": {}, "score": "83.083824"}
{"text": "Although AVAGAST did not reach its primary objective , adding bevacizumab to chemotherapy was associated with significant increases in progression - free survival and overall response rate in the first - line treatment of advanced gastric cancer [ 34 ] . hERG1 .", "label": "", "metadata": {}, "score": "83.08433"}
{"text": "Tumour samples and medical records from patients who had been consecutively evaluated in our institutions for advanced GC treatment between January 2007 and December 2009 were retrospectively reviewed .", "label": "", "metadata": {}, "score": "83.09478"}
{"text": "PubMed View Article .Breast Canc Res Treat 2013 , 138 ( 1 ) : 99 - 108 .View Article .Pathol Int 2012 , 62 ( 11 ) : 728 - 734 .", "label": "", "metadata": {}, "score": "83.116936"}
{"text": "HER2 -amplified tumours .All HER2 -amplified cases were moderately differentiated , and most had a diffuse or at least focally macroglandular architecture .Abbreviations : + present ; - absent ; COPD chronic obstructive pulmonary disease ; CT computed tomography ; FISH fluorescence in situ hybridization ; IHC immunohistochemistry ; ND not determined ; PDAC pancreatic ductal adenocarcinoma .", "label": "", "metadata": {}, "score": "83.12014"}
{"text": "Multivariate survival analyses were determined using a Cox proportional hazards regression model for each of the HER2 variables together with clinical variables recognised as prognostic factors ( peritoneal spread , non - intestinal type and presence of hepatic metastases ) including risk ratios and 95 % CI .", "label": "", "metadata": {}, "score": "83.18921"}
{"text": "CMAJ 2007 , 176 ( 10 ) : 1429 - 1434 .PubMed View Article .Cohen J : A Coefficient of Agreement for Nominal Scales .", "label": "", "metadata": {}, "score": "83.22734"}
{"text": "Two of the investigators ( CGM , FLR ) selected the most appropriate block and performed the interpretation of the different assays in a blinded manner to each other 's results .", "label": "", "metadata": {}, "score": "83.25917"}
{"text": "Actual results may differ materially from those projected in any forward - looking statement .You should not place undue reliance on any forward - looking statements .", "label": "", "metadata": {}, "score": "83.32769"}
{"text": "Training of the US reference laboratory was performed by UH and SM .Data analysis was performed by JM and JM wrote the manuscript with help from UH , SM and AS .", "label": "", "metadata": {}, "score": "83.39015"}
{"text": "Study results showed that margetuximab was well tolerated at all explored doses , including the highest dose tested , 6.0 mg / kg qw .Infusion reactions were well controlled with pre - medications .", "label": "", "metadata": {}, "score": "83.46907"}
{"text": "Studies employing IHC have generally found higher discordance rates than those employing in situ hybridization , suggesting methodological issues may play a role in apparent discordance .", "label": "", "metadata": {}, "score": "83.472466"}
{"text": "The HER family comprises four different receptors : HER1 ( EGFR or ErbB1 ) , HER2 ( ErbB2 or HER-2/Neu ) , HER3 ( ErbB3 ) , and HER4 ( ErbB4 ) ( Figure 3 ) .", "label": "", "metadata": {}, "score": "83.52737"}
{"text": "Data provided are for informational purposes only .Although carefully collected , accuracy can not be guaranteed .The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .", "label": "", "metadata": {}, "score": "83.57088"}
{"text": "The heterogeneity of breast tumor cell populations Figure 4 The heterogeneity of breast tumor cell populations .The heterogeneity of breast cancer cells was demonstrated with brightfield double in situ hybridization ( BDISH ) stained tissue sections .", "label": "", "metadata": {}, "score": "83.65965"}
{"text": "Interestingly , the use of aqueous mounting medium onto the dried tissue slides produced yellowish background staining on tissue sections and this method did not produce satisfactory results ( data not shown ) .", "label": "", "metadata": {}, "score": "83.703"}
{"text": "Expert Opin Drug Deliv 2010 , 7 : 273 - 284 .PubMed View Article .Biankin AV , Hudson TJ : Somatic variation and cancer : therapies lost in the mix .", "label": "", "metadata": {}, "score": "83.7612"}
{"text": "Advantages of the SISH assay com- pared to the CISH assay include that the SISH assay pro- duces signal clusters and separately visualized discrete black dots that are easier to count in the majority of clini- cal samples .", "label": "", "metadata": {}, "score": "84.11392"}
{"text": "The benefits of trastuzumab in metastatic breast and gastric cancer accrue primarily to patients with the highest level of HER2 expression ( HER2 3 + by immunohistochemistry ) or those who have gene - amplified tumors .", "label": "", "metadata": {}, "score": "84.12019"}
{"text": "Speel EJ , Jansen MP , Ramaekers FC , Hopman AH : A novel triple- color detection procedure for brightfield microscopy , com- bining in situ hybridization with immunocytochemistry .", "label": "", "metadata": {}, "score": "84.18028"}
{"text": "Patient demography , local laboratory determination of breast cancer pathological characteristics , management of primary and recurrent disease and follow - up information had been recorded prospectively over time in a secure database .", "label": "", "metadata": {}, "score": "84.35459"}
{"text": "147 - 151 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. A. Tkachenko , N. Z. Zhannat , L. V. Erman et al . , \" Dramatic changes in the prevalence of Helicobacter pylori infection during childhood : a 10-year follow - up study in Russia , \" Journal of Pediatric Gastroenterology and Nutrition , vol .", "label": "", "metadata": {}, "score": "84.785034"}
{"text": "PubMed View Article .Law LY : Dramatic response to trastuzumab and Paclitaxel in a patient with human epidermal growth factor receptor 2-positive metastatic cholangiocarcinoma .", "label": "", "metadata": {}, "score": "84.83978"}
{"text": "The entire assay procedure ( deparaffinisation , pretreatment , hybridisation , stringency wash , signal detection and counterstaining ) was fully automated .Resolution of discordant cases : RT - PCR .", "label": "", "metadata": {}, "score": "84.85145"}
{"text": "106 - 110 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . F. Graziano , F. Arduini , A. Ruzzo et al . , \" Prognostic analysis of E - cadherin gene promoter hypermethylation in patients with surgically resected , node - positive , diffuse gastric cancer , \" Clinical Cancer Research , vol .", "label": "", "metadata": {}, "score": "84.8734"}
{"text": "OS was measured from the date of diagnosis of metastatic disease until the date of death or last follow - up if alive .PFS was defined as the time from date of diagnosis of metastatic disease until first documentation of PD or death for any cause .", "label": "", "metadata": {}, "score": "84.98845"}
{"text": "Due to the social impact of GC , there is a need to stratify patients into appropriate screening , surveillance , or treatment programs .Although histopathology remains the most reliable and less expensive method , numerous efforts have been made to identify and validate novel biomarkers to accomplish the above goals .", "label": "", "metadata": {}, "score": "85.12451"}
{"text": "Hicks DG , Tubbs RR : Assessment of the HER2 Status in Breast Cancer by Fluorescence In - Situ Hybridization ( FISH ) : a Technical Review with Interpretative Guidelines .", "label": "", "metadata": {}, "score": "85.30278"}
{"text": "All cases were scored by a single pathologist ( AM ) , blinded as to the status of the paired sample .Statistical consideration .The agreement between the HER2 gene amplification status of the primary and recurrent lesion was assessed using a kappa test .", "label": "", "metadata": {}, "score": "85.33673"}
{"text": "Norum J , Olsen JA , Wist EA , L\u00f8nning PE : Trastuzumab in adju- vant breast cancer therapy .A model based cost - effec- tivemess analysis .", "label": "", "metadata": {}, "score": "85.344696"}
{"text": "Trastuzumab , a recombinant monoclonal antibody targeting HER2 protein , is now being applied not only in metastatic breast cancer cases but also to localized cases as adjuvant therapy [ 9,10].", "label": "", "metadata": {}, "score": "85.43222"}
{"text": "Trastuzumab , a recombinant monoclonal antibody targeting HER2 protein , is now being applied not only in metastatic breast cancer cases but also to localized cases as adjuvant therapy [ 9 , 10 ] .", "label": "", "metadata": {}, "score": "85.43222"}
{"text": "Hanna W , O'malley FP , Barnes P , Berendt R , Gaboury L , Magliocco A , Pettigrew N , Robertson S , Sengupta S , T\u00eatu B , Thomson T : Undated recommendation from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer .", "label": "", "metadata": {}, "score": "85.47632"}
{"text": "Ten patients ( 3 % ) showed positive co - expression of HER2 , EGFR , and c - MET .After a median follow - up time of 58.4 months with 280 deaths , there was no significant difference in overall survival ( OS ) in terms of HER2 and EGFR status .", "label": "", "metadata": {}, "score": "85.52904"}
{"text": "PubMed View Article .Botterweck AA , Schouten LJ , Volovics A , Dorant E , van Den Brandt PA : Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries .", "label": "", "metadata": {}, "score": "85.53869"}
{"text": "However , there is a nega- tive aspect to trastuzumab therapy , namely cardiac toxic- ity [ 3 ] , which is possibly due to myocardial HER2 gene over - expression associated with anthracycline treatment [ 8 ] and substantial cost .", "label": "", "metadata": {}, "score": "85.96737"}
{"text": "( Table 2 ) .Eighty percent of patients received adjuvant chemotherapy with 10 patients receiving adjuvant trastuzumab in the context of a clinical trial .", "label": "", "metadata": {}, "score": "86.15538"}
{"text": "None of the authors has an affiliation or conflict of interest .Authors ' contributions .Study concept and design : JY , NL .Analysis and interpretation of data : LS , JY .", "label": "", "metadata": {}, "score": "86.19404"}
{"text": "Pretreatment was carried out with the Paraffin Pretreatment Kit ( VysisAbbott ) .When the ratio was between 1.8 and 2.2 , signals in another 20 nuclei were counted , and the HER2/CEP17 ratio in a total of 40 nuclei was determined .", "label": "", "metadata": {}, "score": "86.218735"}
{"text": "Reaction Buffer was used for the washing steps during immunological detection .Liquid Coverslip \u2122 ( LCS , a hydrophobic reagent , Ventana ) was used for controlling liquid evaporation throughout the assay .", "label": "", "metadata": {}, "score": "86.2652"}
{"text": "A development goal for margetuximab is to enable the treatment of a broader population of patients than those eligible for treatment with current HER2-targeted therapies .", "label": "", "metadata": {}, "score": "86.348915"}
{"text": "faint / barely perceptible membranous reactivity ( 1 + ) in tumor cells ( original magnification , \u00d7200 ) .D .no staining ( 0 ) in tumor cells ( original magnification , \u00d7200 ) .", "label": "", "metadata": {}, "score": "86.35142"}
{"text": "References .Jemal A , Siegel R , Xu J , Ward E : Cancer statistics 2010 .CA Cancer J Clin 2010 , 60 : 277 - 300 .", "label": "", "metadata": {}, "score": "86.363785"}
{"text": "We have found that the number of equivocal cases influences the concordance rate with the ASCO / CAP scoring method .There were 4 equivocal cases based on FISH scores and all cases showed the BDISH score disagreement by at least 2 observers .", "label": "", "metadata": {}, "score": "86.37368"}
{"text": "Normal cells should exhibit the ratio expected for normal diploid cells with a one to one relationship of red and blue signals .FISH testing .", "label": "", "metadata": {}, "score": "86.42266"}
{"text": "Subsequently , whole genome sequence analysis on this patient 's tumour confirmed mutation in KRAS p .G12V .The second patient had an atypical pattern of metastatic disease at diagnosis , with a small primary pancreatic tumour on imaging , histologically confirmed peritoneal disease in the pelvis , and nodules in the lungs .", "label": "", "metadata": {}, "score": "86.73743"}
{"text": "Biopsy of the sacrum demonstrated metastatic breast cancer and the patient was commenced on trastuzumab - based treatment , in a clinical trial setting .Following 28 months of objective disease control , she developed progressive bone disease and locoregional recurrence in the left breast .", "label": "", "metadata": {}, "score": "86.89045"}
{"text": "On the other hand , the SISH method produces discrete metallic silver black signals .Horseradish peroxidase ( HRP ) of the detection system reacts with silver acetate , hydroquinone , and H2O2 and deposits metallic silver particles at the reaction site .", "label": "", "metadata": {}, "score": "86.91326"}
{"text": "The results of this trial have prompted the use of IHC test followed by FISH in IHC2 + cases for HER2 diagnostics .Dual colour silver enhanced in situ hybridisation ( dc - SISH ) is a new technique which combines the accuracy of the FISH technique and the morphological control of the IHC technique .", "label": "", "metadata": {}, "score": "86.924255"}
{"text": "( XLSX 683 KB ) .13073_2013_477_MOESM11_ESM . xlsx Additional file 11 : Table S10 : Clinical trials of HER2 -amplified cancers , excluding breast and stomach ( gastric ) cancers .", "label": "", "metadata": {}, "score": "86.92609"}
{"text": "Patients had received treatment in line with the institution usual practice and data on tumour response had been assessed according to Response Evaluation Criteria in Solid Tumours criteria and recorded in the patient 's medical record .", "label": "", "metadata": {}, "score": "87.08934"}
{"text": "Methods .Information collected prospectively was analysed for all patients seen from 1999 to 2009 with primary breast cancer and who had biopsy of a local or distant recurrence .", "label": "", "metadata": {}, "score": "87.200745"}
{"text": "Breast cancers with obvious tumor cell heterogeneity are shown as examples in Figure 4 .However , the subtle genotype heterogeneity of tumor cell populations is often seen among the equivocal cases , and it also can be seen in Figures 3D & 4B which show less obvious variegated tumor cell heterogeneity .", "label": "", "metadata": {}, "score": "87.36078"}
{"text": "Scoring occurred at different sites and at different occasions using different microscopes .Each individual observer evaluated the set of slides at their own pace and judgement .", "label": "", "metadata": {}, "score": "87.42066"}
{"text": "FISH was employed as either the primary assay in cases received for testing prior to 2006 , or as a confirmatory assay in cases received after 2006 with non - diagnostic or equivocal SISH results .", "label": "", "metadata": {}, "score": "87.52558"}
{"text": "Dual - colour HER2/Chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples .", "label": "", "metadata": {}, "score": "87.6169"}
{"text": "IHC assists the pathologists in areas of tumor classification , multilineage differentiation , molecular correlates , and infectious etiologies .Moreover , IHC is commonly used to detect markers , which in turn can provide information on the biological behaviour and prognosis of a tumor .", "label": "", "metadata": {}, "score": "87.62981"}
{"text": "Br J Cancer 2012 , 106 : 1033 - 1038 .PubMed View Article .J Clin Oncol 2009 , 27 : 1160 - 1167 .", "label": "", "metadata": {}, "score": "87.78653"}
{"text": "4 , pp .428 - 432 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Lauren , \" The two histological main types of gastric carcinoma : diffuse and so - called intestinal type carcinoma , \" Acta Pathologica et Microbiologica Scandinavica , vol .", "label": "", "metadata": {}, "score": "87.92854"}
{"text": "Trastuzumab , a monoclonal antibody that targets the HER2 receptor , is an effective therapy for HER2 -amplified breast cancer , and was recently extended to the treatment of HER2 -amplified gastric cancer [ 11 ] .", "label": "", "metadata": {}, "score": "87.940704"}
{"text": "In our cohort of 469 patients , the incidence of lung metastases without liver metastases was 8 % , comparable to previous studies .We detected only one case with brain metastases ( 0.2 % ) , although only this single patient was investigated specifically for brain metastases .", "label": "", "metadata": {}, "score": "88.00704"}
{"text": "6888 ) to A. Arcangeli .The authors thank Oscar Campos for helping in the execution of drawings .J. Chen , X. L. Bu , Q. Y. Wang , P. J. Hu , and M. H. Chen , \" Decreasing seroprevalence of Helicobacter pylori infection during 1993 - 2003 in Guangzhou , southern China , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "88.10264"}
{"text": "The present study revealed a high concordance rate , 98.5 % , between IHC and FISH , which is similar to another study of surgical resections from 145 Chinese GC cases , with a concordance rate of 94.5 % [ 26 ] .", "label": "", "metadata": {}, "score": "88.202705"}
{"text": "4 , pp .566 - 571 , 1999 .View at Publisher \u00b7 View at Google Scholar .37 , no . 7 , pp .", "label": "", "metadata": {}, "score": "88.29665"}
{"text": "An orthogonal approach by which a primary molecular classification is used and patients are sub - classified based on organ of origin may be more tractable .", "label": "", "metadata": {}, "score": "88.62999"}
{"text": "bright - field 27 .J Natl Cancer Inst 2002 , 94:852 - 854 .Roche PC , Suman VJ , Jenkins RB , Davidson NE , Martino S , Kaufman PA , Addo FK , Murphy B , Ingle JN , Perez EA : Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831 .", "label": "", "metadata": {}, "score": "88.72777"}
{"text": "Kamangar F , Dores GM , Anderson WF : Patterns of cancer incidence , mortality , and prevalence across five continents : defining priorities to reduce cancer disparities in different geographic regions of the world .", "label": "", "metadata": {}, "score": "88.736664"}
{"text": "The patients ' medical records were reviewed to obtain patients ' clinicopathological parameters , including age at diagnosis , sex , tumor location , histological classification , and pathological TNM stage .", "label": "", "metadata": {}, "score": "88.886536"}
{"text": "Methods Both FISH and IHC were applied to 200 tumours from 196 consecutive patients who underwent resection of primary breast cancer with the sentinel procedure and/or axillary dissection .", "label": "", "metadata": {}, "score": "89.05986"}
{"text": "As shown in Figure 1 , I - GC occurrence is preceded by the development of chronic gastritis , which in turn leads to atrophy , and by the subsequent appearance of intestinal metaplasia .", "label": "", "metadata": {}, "score": "89.30795"}
{"text": "Conclusions The anti - MET antibody clone A2H2 - 3 displays excellent specificity and sensitivity .These properties make it suitable for clinical trial investigations and development as a potential companion diagnosticThis article is protected by copyright .", "label": "", "metadata": {}, "score": "89.546616"}
{"text": "The variation in reported results may relate to several factors .Our study underscores the difficulties in assessing paired primary and recurrent tumour specimens when analysis is performed in a retrospective fashion with 26 % of specimens having insufficient material available for in situ hybridisation .", "label": "", "metadata": {}, "score": "89.62647"}
{"text": "ROCKVILLE , Md. , June 3 , 2013 /PRNewswire/ -- MacroGenics , Inc. announced that results of the first - in - human study of margetuximab were reported during an oral abstract session today at the 2013 Annual Meeting of the American Society of Clinical Oncology ( ASCO ) .", "label": "", "metadata": {}, "score": "89.63166"}
{"text": "Single nucleotide variations ( SNVs ) and small insertions or deletions ( indels ) annotated and compared with data from dbSNP , COSMIC , TCGA Breast , Biankin et al .", "label": "", "metadata": {}, "score": "89.75094"}
{"text": "AC designed study , performed the clinical assessments , analysed the data and prepared the manuscript .AM , BB , performed the laboratory experiments and analysed the data and prepared the methodology section of the manuscript .", "label": "", "metadata": {}, "score": "89.961334"}
{"text": "The authors concluded that the targeting of VEGF - D might be therefore a potential therapeutic strategy .Besides controversies in the interpretation of IHC data , the Avastin in Gastric Cancer ( AVAGAST ) trial started in 2007 .", "label": "", "metadata": {}, "score": "89.99963"}
{"text": "Fluorescent in situ hybridisation was only possible in 68 paired samples and there were 5 discordant cases ( 7 % ) ; 3 metastases gaining amplification vs a non - amplified primary , and 2 metastases becoming non - amplified .", "label": "", "metadata": {}, "score": "90.300476"}
{"text": "Margetuximab ( MGAH22 ) , an Fc - modified monoclonal antibody , targets the HER2 oncoprotein , which is overexpressed on the surface of various cancer cells and plays an important role in tumorigenesis , tumor aggressiveness , and outcome in breast and other cancers .", "label": "", "metadata": {}, "score": "90.48427"}
{"text": "Consent was waived by Human Research Ethics Committees for retrospectively acquired data and material under an approved protocol ( see Additional file 2 ) .Genomic sequencing , copy number , and mRNA expression analysis .", "label": "", "metadata": {}, "score": "90.56902"}
{"text": "Brightfield in situ hybridization The BenchMark \u00ae XT automated slide processing system ( Ventana Medical Systems , Inc. , Tucson , Arizona ) was used for the optimization and performance evaluation of the BDISH assay for HER2 and CEN 17 DNA targets .", "label": "", "metadata": {}, "score": "90.57034"}
{"text": "Specimens with a ratio between 1.8 and 2.2 ( borderline cases ) were subjected to additional enumeration of 20 nuclei and the ratio was then recalculated for the 40 nuclei to determine if amplification was present or not .", "label": "", "metadata": {}, "score": "90.641464"}
{"text": "This variation may be partly explained by different sample sets .In the ToGA trial , the countries with the highest ratio of GEJ : stomach cancer were found to have above - average HER2-positivity rates , regardless of sample size [ 23 ] .", "label": "", "metadata": {}, "score": "90.7075"}
{"text": "PubMed View Article .Abdi - Rad A , Ghaderi - sohi S , Nadimi - Barfroosh H , Emami S : Trend in incidence of gastric adenocarcinoma by tumor location from 1969 - 2004 : a study in one referral center in Iran .", "label": "", "metadata": {}, "score": "90.805885"}
{"text": "Methods .Ethics approval .Ethics approval for acquisition of data and biological material was obtained from the human research ethics committee at each participating institution , conducted in accordance with the National Statement on Ethical Conduct in Human Research 2007 and the Declaration of Helsinki .", "label": "", "metadata": {}, "score": "90.89046"}
{"text": "The reasons of the different conclusions drawn by several groups might be related to the design of the study and sample characteristics as well as geographical differences , keeping in mind that GC is a complex disease with striking differences in different countries .", "label": "", "metadata": {}, "score": "90.99543"}
{"text": "Breast Can- cer Res 2007 in press .Lab Invest 2006 , 86:398 - 408 .J Clin Oncol 2006 , 24:3032 - 3038 .Page 12 .", "label": "", "metadata": {}, "score": "91.03845"}
{"text": "The kappa score for paired samples as assessed by immunohistochemistry was 0.616 , which demonstrates good agreement .For in situ hybridisation , the kappa score of 0.979 ( 95 % CI 0.939 - 1.02 ) indicates very good agreement .", "label": "", "metadata": {}, "score": "91.06091"}
{"text": "PubMed View Article .Ann Surg 2007 , 246 : 734 - 740 .PubMed View Article .J Clin Oncol 2009 , 27 : 1806 - 1813 .", "label": "", "metadata": {}, "score": "91.12138"}
{"text": "NSCLC : .Non - small cell lung cancer .PDAC : .Pancreatic ductal adenocarcinoma .SNP : .Single nucleotide polymorphism .TCGA : .", "label": "", "metadata": {}, "score": "91.18764"}
{"text": "Declarations .Funding / support .Acknowledgments .We also thank Mary - Anne Brancato BSc , Michelle Thomas BSc , Sarah Rowe BSc , and Mona Martyn - Smith BSc for maintenance of the APGI database and biospecimen resource .", "label": "", "metadata": {}, "score": "91.578766"}
{"text": "VEGF .The vascular endothelial growth factor ( VEGF ) family is a multifunctional growth factors ' family , involved in processes such as angiogenesis , inflammation , and vascular regeneration .", "label": "", "metadata": {}, "score": "91.61906"}
{"text": "None of the eight cases with a documented site of recurrence had liver metastases ( one patient had recurrence , and for another patient the site of recurrence was not reported ) .", "label": "", "metadata": {}, "score": "91.64784"}
{"text": "Declarations .Acknowledgements .This study was supported by grants from the Beijing Hope Run Special Fund ( LC2012A08 ) and the National Natural Science Foundation of China ( 30801344 ) .", "label": "", "metadata": {}, "score": "91.8871"}
{"text": "Histopathology 2011 ; 59 : 8 - 17 . . .New guidelines to evaluate the response to treatment in solid tumors .European Organization for Research and treatment of cancer , National cancer Institute of the United States , National cancer Institute of Canada .", "label": "", "metadata": {}, "score": "92.142456"}
{"text": "Thus , trastuzumab was recently approved for the treatment of metastatic adenocarcinomas of the stomach and GEJ in many countries [ 12 - 17 ] .", "label": "", "metadata": {}, "score": "92.144485"}
{"text": "Mol Cancer Ther 2006 , 5:2572 - 2579 .Breast Cancer Res 2005 , 7:R267-R273 .Eur J Cancer 2007 , 43:2339 - 2344 .", "label": "", "metadata": {}, "score": "92.30965"}
{"text": "Cancer Discov 2011 , 1 : 44 - 53 .PubMed View Article .J Clin Oncol 2012 , 30 : 3242 - 3249 .PubMed View Article .", "label": "", "metadata": {}, "score": "92.420494"}
{"text": "For the second color for the BDISH application , DAB , BCIP / NBT , and TMB detection systems that produce brown , blue , and green to blue final product , respectively , were evaluated .", "label": "", "metadata": {}, "score": "92.539734"}
{"text": "Concluding Remarks .Histopathology still represents the most powerful tool for gastric cancer management and , in recent years , novel biomarkers have been identified and tested for their correlations with clinical parameters as well as prognosis .", "label": "", "metadata": {}, "score": "92.580826"}
{"text": "All authors contributed intellectual inputs to the study .All authors read and approved the final manuscript .Acknowledgements We would like to thank Vu Nguyen for instrument maintenance and Drs .", "label": "", "metadata": {}, "score": "93.10405"}
{"text": "Ethics approval The ethics approval was provided by the Ethics Committee / Institutional Review Board at Centro Integral de Oncologia Clara Campal .Provenance and peer review Not commissioned ; externally peer reviewed . . .", "label": "", "metadata": {}, "score": "93.11961"}
{"text": "In PDAC , clinical trial data indicate that the first site of distant metastases occurred most commonly in the liver ( 50 % ) , and occurred in the lung in 9 % of the cases [ 23 ] .", "label": "", "metadata": {}, "score": "93.13822"}
{"text": "( C ) Circos plot showing mutations and structural rearrangements of patient 9 ( Table 2 ) .Genes with non - silent substitutions are shown on the outer wheel .", "label": "", "metadata": {}, "score": "93.16431"}
{"text": "Samuel N , Hudson TJ : The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma .Nature Rev Gastroenterol Hepatol 2012 , 9 : 77 - 87 .", "label": "", "metadata": {}, "score": "93.23055"}
{"text": "Primary breast cancer tissue sections were obtained from formalin - fixed paraffin embedded blocks and recurrent tumour samples were collected mainly as core biopsies or cell blocks prepared from centrifuged fine needle aspirations .", "label": "", "metadata": {}, "score": "93.25414"}
{"text": "The most common adverse events ( AEs ) were Grade 1 - 2 constitutional symptoms and infusion - related reactions .Additionally , related AEs greater than or equal to Grade 3 were limited to a single infusion reaction , two episodes of brief lymphopenia confounded by steroids , and transient worsening anemia .", "label": "", "metadata": {}, "score": "93.31926"}
{"text": "Current diagnostic methods , including fluorescent in situ hybridisation and immunohistochemistry , can be subjective and insensitive .\" [ Show abstract ] [ Hide abstract ] ABSTRACT : Reverse transcription quantitative PCR is an established , simple and effective method for RNA measurement .", "label": "", "metadata": {}, "score": "94.348785"}
{"text": "6 Laboratorio de Dianas Terap\u00e9uticas , Centro Integral Oncol\u00f3gico ' Clara Campal ' , Hospital Universitario Madrid Sanchinarro , Universidad San Pablo - CEU , Facultad de Medicina , Madrid , Spain .", "label": "", "metadata": {}, "score": "94.503075"}
{"text": "31 - 49 , 1965 .View at Google Scholar \u00b7 View at Scopus .P. Correa , \" Human gastric carcinogenesis : a multistep and multifactorial process - First American Cancer Society Award lecture on cancer epidemiology and prevention , \" Cancer Research , vol .", "label": "", "metadata": {}, "score": "94.56536"}
{"text": "Ninety - four ( 94 ) breast cancer cases were used from the Cleveland Clinic Foundation and the Cleveland Clinic Lerner College of Medicine , Cleveland , OH , USA under IRB approved protocol .", "label": "", "metadata": {}, "score": "94.68741"}
{"text": "Immunohistochemistry .Automated IHC was performed on 4-\u03bcm - thick sections using an automated slide stainer , the Ventana Benchmark XT ( Ventana Medical Systems , Tucson , AZ , USA ) , according to the manufacturer 's instructions , for the Ventana CONFIRM \u2122 HER2/neu ( 4B5 ) Rabbit Monoclonal Primary Antibody .", "label": "", "metadata": {}, "score": "94.75197"}
{"text": "Such indications for extension of existing therapeutics is attractive ; however , specific molecular phenotypes and diagnostic characteristics are complex and usually inadequately defined [ 4 , 5 ] .", "label": "", "metadata": {}, "score": "94.97843"}
{"text": "Differing provisions from the publisher 's actual policy or licence agreement may be applicable . \"As such , they are offered only to those patients for whom there is definitive molecular proof that they harbour the associated specific mutation .", "label": "", "metadata": {}, "score": "95.43045"}
{"text": "Of all patients , there were 650 cases ( 44.4 % ) of intestinal type by Lauren 's classification , 564 cases ( 38.6 % ) of diffused type , and 249 cases ( 17 % ) of mixed type .", "label": "", "metadata": {}, "score": "95.65857"}
{"text": "Paraffin tissue sections on glass slides were baked at 65 \u00b0 C for 20 minutes prior to the deparaffi- nization step with EZ Prep \u2122 ( Ventana ) at 75 \u00b0 C for 16 minutes .", "label": "", "metadata": {}, "score": "95.72174"}
{"text": "Patient consent We report our results in a series of gastric cancer patients treated for their disease .There are no personal data in our manuscript .", "label": "", "metadata": {}, "score": "95.93106"}
{"text": "PubMed View Article .J Clin Oncol 2012 , 30 : 593 - 599 .PubMed View Article .J Clin Oncol 2012 , 30 : 587 - 592 .", "label": "", "metadata": {}, "score": "95.93457"}
{"text": "Unresectable or recurrent gastric or gastroesophageal junction cancer patients with histologically confirmed adenocarcinoma treated with S-1 plus cisplatin as first - line chemotherapy were eligible .", "label": "", "metadata": {}, "score": "96.21053"}
{"text": "PubMed View Article .Breast Cancer Res 2007 , 9 : R31 .PubMed View Article .Clin Cancer Res 2011 , 17 : 2055 - 2064 .", "label": "", "metadata": {}, "score": "96.21773"}
{"text": "Slides were blot- ted very gently with paper towels and completely dried at 45 \u00b0 C or 65 \u00b0 C in the oven for at least 15 minutes .", "label": "", "metadata": {}, "score": "96.258804"}
{"text": "J Clin Oncol 2009 , 27 : 2855 - 2862 .PubMed View Article .Annal Oncol 2012 , 23 : 1713 - 1722 .View Article .", "label": "", "metadata": {}, "score": "96.33786"}
{"text": "Conclusion .Declarations .Acknowledgements .We thank USLABS in Irvine for a successful and professional collaboration .Jan Tr\u00f8st J\u00f8rgensen is acknowledged for excellent scientific help .", "label": "", "metadata": {}, "score": "96.55913"}
{"text": "The study was performed in accordance with the current version of the World Medical Association Declaration of Helsinki and approval from an Institutional Review Board ( Copernicus Group , Inc. ) was granted prior to study start .", "label": "", "metadata": {}, "score": "96.68418"}
{"text": "Histological examinations from biopsies were obtained during an endoscopy in 40 ( 27.0 % ) patients and from surgical specimens in 108 ( 72.9 % ) patients of whom 12 ( 8.1 % ) were from distant metastases ( eight peritoneal implants and four liver metastases ) .", "label": "", "metadata": {}, "score": "96.775"}
{"text": "Electronic supplementary material .The online version of this article ( doi : 10 .1186/\u200bgm482 ) contains supplementary material , which is available to authorized users .", "label": "", "metadata": {}, "score": "96.80136"}
{"text": "AC has received honoraria and research grant for educational speaking engagements / consultancy advice and investigator - initiated study , respectively .AM , BB , DH , PW , DI have no conflicts of interest to declare .", "label": "", "metadata": {}, "score": "96.80553"}
{"text": "IBM SPSS Statistics were used for statistical work ( SPSS Inc. , Chicago , IL ) .Agreement calculations were reported with 95 % confidence limits based on the binomial distribution using equal tailed Jeffreys prior intervals [ 11 ] as calculated by the PROPOR plug - in .", "label": "", "metadata": {}, "score": "97.07619"}
{"text": "CTC : .Circulating tumour cells .Declarations .Acknowledgment .The study was supported by Roche Products Pty Limited ( Australia ) .Minor editorial assistance ( formatting ) was provided by Dr Joseline Ojaimi from Roche Products .", "label": "", "metadata": {}, "score": "97.31708"}
{"text": "Formalin - fixed , paraffin wax - embedded diagnostic material from a cohort of 469 patients who had undergone operative resection for PDAC was accrued from 12 institutions associated with the APGI between 1990 and 2012 .", "label": "", "metadata": {}, "score": "97.32735"}
{"text": "Excess mounting media was removed from the slides by gently pressing the slides against paper towels .Different coverslipping methods were also evaluated for preserving the fast red staining during the assay development .", "label": "", "metadata": {}, "score": "97.50369"}
{"text": "Therefore , IHC represents a link between surgical and molecular pathology , basic science and clinical medicine , surgery , and radiology [ 13 ] .", "label": "", "metadata": {}, "score": "97.54448"}
{"text": "Statements made in this news release that are not historical facts are forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 .", "label": "", "metadata": {}, "score": "97.62132"}
{"text": "GC is characterized by a clear geographical distribution , with over 70 % of the cases occurring in developing countries .This is partly due to dietary habits as well as Helicobacter pylori infection prevalence .", "label": "", "metadata": {}, "score": "97.842354"}
{"text": "2 GC is often diagnosed at an advanced stage where curative radical gastrectomy is generally unfeasible and , consequently , survival rate for GC at 5 years of diagnosis is under 27 % .", "label": "", "metadata": {}, "score": "97.99794"}
{"text": "Affiliated with .Abstract .Background .Pancreatic cancer is one of the most lethal and molecularly diverse malignancies .Repurposing of therapeutics that target specific molecular mechanisms in different disease types offers potential for rapid improvements in outcome .", "label": "", "metadata": {}, "score": "98.31696"}
{"text": "PubMed View Article .Breast Cancer Res 2007 , 9 : R74 .PubMed View Article .Cancer 2005 , 104 : 257 - 263 .", "label": "", "metadata": {}, "score": "98.353966"}
{"text": "MacroGenics is a leader in the discovery and development of innovative medicines that utilize its next - generation antibody - based technologies .The company is advancing a pipeline of product candidates to treat patients with cancer and other serious , complex diseases .", "label": "", "metadata": {}, "score": "98.56944"}
{"text": "The consensus among observers was defined as the agreement of three or more observers on a given observation .The sensitivity was 100 % and the specificity was also 100 % .", "label": "", "metadata": {}, "score": "99.221794"}
{"text": "PubMed View Article .Clin Cancer Res 2006 , 12 : 4925 - 4932 .PubMed View Article .Cancer Invest 2004 , 22 : 706 - 712 .", "label": "", "metadata": {}, "score": "99.34796"}
{"text": "J Clin Pathol 2010 , 63 ( 9 ) : 839 - 842 .PubMed View Article .Copyright .\u00a9 Shan et al . ; licensee BioMed Central Ltd. 2013 .", "label": "", "metadata": {}, "score": "99.40664"}
{"text": "Two tailed 95 % confidence intervals are based on the binomial distribution .Success rates .Final success rates were determined after allowing for two staining runs .", "label": "", "metadata": {}, "score": "99.634735"}
{"text": "Histopath Pathology .Macarthur Cancer Therapy Centre , Sydney South West District Health Service .Upper Gastrointestinal Surgery Unit , Royal North Shore Hospital .Wolfson Wohl Cancer Research Centre , Institute of Cancer Sciences , University of Glasgow .", "label": "", "metadata": {}, "score": "100.69325"}
{"text": "Authors ' Contribution . E. Lastraioli and M. R. Romoli contributed equally to the work .Acknowledgments .This work was supported by Associazione Italiana per la Ricerca sul Cancro ( AIRC , Grant no .", "label": "", "metadata": {}, "score": "100.98731"}
{"text": "Clinicopathological data from all patients were collected .Progression free survival and overall survival were also analysed .Results Mean age was 67 ( 33 - 83 ) years ; 75 % were male subjects , and 51 % had intestinal histological type .", "label": "", "metadata": {}, "score": "101.04263"}
{"text": "These findings have significant clinical implications .First , the detection of small lung nodules should not delay the diagnosis of metastatic disease originating in the pancreas or at relapse if the liver and other sites are clear , particularly in known HER2 -amplified cases .", "label": "", "metadata": {}, "score": "101.19556"}
{"text": "Methods .Samples .All tumor samples were fixed in 10 % neutral buffered formalin for 24 - 48 h and embedded in paraffin , and routinely diagnosed in the Department of Pathology , CICAMS , Beijing .", "label": "", "metadata": {}, "score": "101.49158"}
{"text": "Tumor cells of I - GC form glandular - like structures , a feature which lacks in D - GC , which , on the contrary , is characterized by the infiltration and thickening of the gastric wall by tumor cells .", "label": "", "metadata": {}, "score": "101.58841"}
{"text": "12 , pp .1722 - 1729 , 2000 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .110 , no .", "label": "", "metadata": {}, "score": "101.60307"}
{"text": "U.S.National Institutes of Helath , USA . ; GA Trial Investigators .Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro - oesophageal junction cancer ( ToGA ) : a phase 3 , open - label , randomised controlled trial .", "label": "", "metadata": {}, "score": "101.761086"}
{"text": "Despite some advances in the prevention and treatment of gastric cancer , 5-year survival remains around 20 % in most parts of the world .", "label": "", "metadata": {}, "score": "101.77751"}
{"text": "PubMed View Article .Lancet 2010 , 376 ( 9742 ) : 687 - 697 .PubMed View Article .EMEA and European Medicines Agency O 2009 .", "label": "", "metadata": {}, "score": "101.866844"}
{"text": "Median PFS was 6.14 months ( 95 % CI 5.19 to 7.23 months ) and median OS was 11.37 months ( 95 % CI 9.00 to 13.83 months ) for the entire population .", "label": "", "metadata": {}, "score": "102.37807"}
{"text": "According to the Lauren 's classification , two subtypes of GC can be distinguished basing on their different histology : the intestinal ( I - GC ) and diffuse ( D - GC ) types [ 6 ] .", "label": "", "metadata": {}, "score": "102.50116"}
{"text": "According to the National Cancer Institute , over 230,000 women in the U.S. are diagnosed with breast cancer annually .Of these women , only about 20 % have tumors that are HER2 positive ( IHC 3 + , or HER2 gene - amplified ) .", "label": "", "metadata": {}, "score": "102.790596"}
{"text": "Conversely , the genetic component plays a major role in familial cancers .About 90 % of GCs are classified as adenocarcinomas , whilst the remaining 10 % is represented by non - Hodgkin lymphomas , leiomyosarcomas , squamous cell carcinomas , and undifferentiated carcinomas .", "label": "", "metadata": {}, "score": "102.859634"}
{"text": "Primary tumour mRNA expression was assayed using human microarrays ( HT-12 V4 ; Illumina ) ( GEO accession GSE36924 ) .Gene expression profiles were classified into intrinsic breast cancer subtypes using the PAM50 classifier [ 18 ] .", "label": "", "metadata": {}, "score": "102.91118"}
{"text": "All authors contributed to and approved the final manuscript .Authors ' Affiliations .Mount Hospital .Sydpath , St Vincent 's Hospital .References .", "label": "", "metadata": {}, "score": "103.18657"}
{"text": "Introduction .GC is one of the most frequent tumours in the world with approximately 989 000 new cases and 738 000 deaths per year . 1", "label": "", "metadata": {}, "score": "103.94568"}
{"text": "Positive agreement was 90.9 % ( CI95 : 79.8 % ; 96.9 % ) and negative agreement was 98.7 % ( CI95 : 96.9 % ; 99.6 % )", "label": "", "metadata": {}, "score": "104.12292"}
{"text": "Keywords .HER2 Gastric cancer Gastroesophageal junction adenocarcinoma Chineses Clinicopathological features .Background .Gastric cancer ( GC ) is the fourth most commonly diagnosed cancer and the second most common cause of cancer - related deaths worldwide [ 1 ] .", "label": "", "metadata": {}, "score": "105.885605"}
{"text": "All authors read and approved the final manuscript .Authors ' Affiliations .Department of Pathology , Cancer Hospital , Peking Union Medical College & Chinese Academy of Medical Sciences .", "label": "", "metadata": {}, "score": "105.94667"}
{"text": ": it is composed of four subunits , each of which formed by six transmembrane segments ( S1-S6 ) , which are assembled to form a tetramer surrounding a central aqueous pore .", "label": "", "metadata": {}, "score": "107.01198"}
{"text": "Conclusions This working method and analysis enabled new insights to be obtained into the pathobiology of HER2 in breast cancer .Chicago .Lambein , Kathleen , Marleen Praet , Ramses Forsyth , Rudy Van den Broecke , Geert Braems , BART MATTHYS , Veronique Cocquyt , Hannelore Denys , Patrick Pauwels , and Louis Libbrecht .", "label": "", "metadata": {}, "score": "107.29234"}
{"text": "PubMed .Pre - publication history .Copyright .\u00a9 Mollerup et al ; licensee BioMed Central Ltd. 2012 .", "label": "", "metadata": {}, "score": "107.37883"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Advanced gastric cancer ( GC ) is a dreadful disease with a poor prognosis and the majority of patients die within 1 year of diagnosis .", "label": "", "metadata": {}, "score": "109.9117"}
{"text": "The tumors were poorly differentiated in 73.1 % , moderately differentiated in 25.2 % , and well - differentiated in 1.7 % .Overall , most patients were at pathologic stage T3 ( 73.4 % ) , with 14.1 % , 10 % , and 2.5 % at stage T1 , T2 , and T4 , respectively .", "label": "", "metadata": {}, "score": "110.090416"}
{"text": "Gastric cancer still represents a major health problem , despite a decrease in its incidence in the last years .Due to the social impact of gastric cancer ( GC ) , there is a need for novel biomarkers in order to stratify patients into appropriate screening , surveillance , or treatment programs .", "label": "", "metadata": {}, "score": "110.28688"}
{"text": "The two histological main types of gastric carcinoma : diffuse and so - called intestinal - type carcinoma .An attempt at a histo - clinical classification .", "label": "", "metadata": {}, "score": "110.35309"}
{"text": "Invest New Drugs 2012 , 30 : 695 - 701 .PubMed View Article .Copyright .\u00a9 Chou et al . ; licensee BioMed Central Ltd. 2013 .", "label": "", "metadata": {}, "score": "111.20691"}
{"text": "Tek \u00ae film coverslipper method ( Sakura Finetek Japan , Tokyo , Japan ) after air - drying slides ( data not shown ) .The most common method of coverslipping tissue sec- tions stained with fast red is the use of an aqueous mount- ing medium .", "label": "", "metadata": {}, "score": "111.446945"}
{"text": "398 - 404 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .4 , no . 3 , pp .", "label": "", "metadata": {}, "score": "111.494835"}
{"text": "Structural rearrangements are indicated with lines inside the circle : deletions ( green ) , inversions ( yellow ) , intra - chromosomal rearrangements ( blue ) , foldback inversions ( light orange ) , and amplified inversions ( dark orange ) .", "label": "", "metadata": {}, "score": "112.79922"}
{"text": "Kinghorn Cancer Centre and Garvan Institute of Medical Research .Anatomical Pathology , Sydpath , St Vincent 's Hospital .St Vincent 's Clinical School , University of New South Wales .", "label": "", "metadata": {}, "score": "113.23523"}
{"text": "Pancreatic cancer is the fourth leading cause of cancer death in western societies , with a 5-year survival rate of less than 5 % [ 1 ] .", "label": "", "metadata": {}, "score": "113.468704"}
{"text": "Footnotes .Funding Financial support of research provided by Roche Farma Spain who have no role in conception and design of this research , analysis and interpretation of data , drafting of the article or final approval of the version to be published .", "label": "", "metadata": {}, "score": "113.943016"}
{"text": "299 - 307 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .376 , pp .687 - 697 , 2010 .", "label": "", "metadata": {}, "score": "115.02739"}
{"text": "234 - 241 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .27 ,p. 18s , 2009 .", "label": "", "metadata": {}, "score": "115.22455"}
{"text": "Gastric Cancer .Gastric cancer ( GC ) still represents a major health problem , despite a decrease in its incidence in the last years [ 1 ] .", "label": "", "metadata": {}, "score": "115.67023"}
{"text": "PubMed View Article .Hede K : Superhighway or blind alley ?The cancer genome atlas releases first results .J Natl Cancer Inst 2008 , 100 : 1566 - 1569 .", "label": "", "metadata": {}, "score": "115.94615"}
{"text": "The majority of stomach tumors are sporadic , while only a small percentage have a familial component , with an autosomal pattern of inheritance .GC is a multifactorial disease characterized by both genetic and environmental components .", "label": "", "metadata": {}, "score": "119.53351"}
{"text": "Immunohistochemical Biomarkers in Gastric Cancer Research and Management .Department of Experimental Pathology and Oncology , University of Florence , 50134 Florence , Italy .Received 16 February 2012 ; Revised 22 April 2012 ; Accepted 25 April 2012 .", "label": "", "metadata": {}, "score": "120.36417"}
{"text": "Sydney Medical School , University of Sydney .Queensland Centre for Medical Genomics , Institute for Molecular Bioscience , University of Queensland .Department of Cancer Medicine , Hammersmith Hospital , Imperial College Healthcare NHS Trust .", "label": "", "metadata": {}, "score": "124.15361"}
{"text": "View at Publisher \u00b7 View at Google Scholar .18 , no .11 , pp .2201 - 2209 , 2000 .View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "129.03517"}
{"text": "Copyright \u00a9 2012 Elena Lastraioli et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "129.36885"}
{"text": "The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .Publisher conditions are provided by RoMEO .", "label": "", "metadata": {}, "score": "140.78183"}
